MOK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00116 | T68 | Sugiyama | AGPS AAG5 | RPREALSTNECKARRAAsAAtAAPtAtPAAQEsGtIPKKRQ |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00488 | S40 | Sugiyama | ZNF593 ZT86 | KAKRRRPDLDEIHRELRPQGsARPQPDPNAEFDPDLPGGGL |
| O14579 | S307 | Sugiyama | COPE | IKEYQAKENDFDRLVLQyAPsA___________________ |
| O14641 | S648 | Sugiyama | DVL2 | GGSLRRGGEAsGtsDGGPPPsRGstGGAPNLRAHPGLHPYG |
| O14908 | S232 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | TEPRKAFDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAt |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O75122 | S22 | Sugiyama | CLASP2 KIAA0627 | AMGDDKsFDDEEsVDGNRPssAAsAFKVPAPKTSGNPANSA |
| O75822 | T33 | Sugiyama | EIF3J EIF3S1 PRO0391 | sWDADAFsVEDPVRKVGGGGtAGGDRWEGEDEDEDVKDNWD |
| O94804 | S450 | Sugiyama | STK10 LOK | VAEQGGDLsPAANRsQKAsQsRPNssALEtLGGEKLANGsL |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P11142 | T222 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFI |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P12270 | T650 | Sugiyama | TPR | AssLDDVsLAstPKRPstsQtVstPAPVPVIESTEAIEAKA |
| P12277 | S147 | Sugiyama | CKB CKBB | LssRVRTGRSIRGFCLPPHCsRGERRAIEKLAVEALssLDG |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13929 | S14 | Sugiyama | ENO3 | _______MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAA |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | S55 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMNVARLN |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S341 | Sugiyama | HNRNPA2B1 HNRPA2B1 | FGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy________ |
| P22626 | S344 | Sugiyama | HNRNPA2B1 HNRPA2B1 | sRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___________ |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P27695 | S135 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | SHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEG |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P34897 | T420 | Sugiyama | SHMT2 | LELVSITANKNTCPGDRsAItPGGLRLGAPALtSRQFREDD |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P35250 | S30 | Sugiyama | RFC2 | AGEVEAQDSDPAPAFSKAPGsAGHyELPWVEKYRPVKLNEI |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35613 | S278 | Sugiyama | BSG UNQ6505/PRO21383 | ITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQ |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P42166 | S158 | Sugiyama | TMPO LAP2 | tRKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsN |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | S158 | Sugiyama | TMPO LAP2 | TRKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSN |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42679 | S484 | Sugiyama | MATK CTK HYL | EPARRPPFRKLAEKLARELRsAGAPASVsGQDADGstsPRs |
| P42765 | T227 | Sugiyama | ACAA2 | EVKTKKGKQTMQVDEHARPQtTLEQLQKLPPVFKKDGTVTA |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46013 | S299 | Sugiyama | MKI67 | GLQGETQLLVSRKSRPKsGGsGHAVAEPAsPEQELDQNKGK |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P50502 | S181 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | LQKPNAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P54259 | S101 | Sugiyama | ATN1 D12S755E DRPLA | sEETNAPKKTKtEQELPRPQsPsDLDsLDGRsLNDDGSsDP |
| P54652 | T225 | Sugiyama | HSPA2 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLA |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P62195 | T194 | Sugiyama | PSMC5 SUG1 | LFEALGIAQPKGVLLyGPPGtGKTLLARAVAHHTDCTFIRV |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62995 | T201 | Sugiyama | TRA2B SFRS10 | GMELDGRRIRVDFSITKRPHtPtPGIyMGRPtYGssRRRDY |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00059 | S160 | Sugiyama | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q01518 | S301 | Sugiyama | CAP1 CAP | HKNPALKAQSGPVRsGPKPFsAPKPQtsPsPKRATKKEPAV |
| Q01518 | T307 | Sugiyama | CAP1 CAP | KAQSGPVRsGPKPFsAPKPQtsPsPKRATKKEPAVLELEGK |
| Q02543 | T102 | Sugiyama | RPL18A | LRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAH |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q08J23 | S383 | Sugiyama | NSUN2 SAKI TRM4 | QWKVMTKDGQWFTDWDAVPHsRHTQIRPTMFPPKDPEKLQA |
| Q12789 | S846 | Sugiyama | GTF3C1 | ISERRTIKQESGRAGVRPsssGsAWEACSEAPSKGSQDGVT |
| Q13263 | T415 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LNAWTKSAEAFGKIVAERPGtNstGPAPMAPPRAPGPLSKQ |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14135 | S200 | Sugiyama | VGLL4 KIAA0121 | CPIAHSGCAAPGPASYRRPPsAAttCDPVVEEHFRRSLGKN |
| Q14135 | T204 | Sugiyama | VGLL4 KIAA0121 | HSGCAAPGPASYRRPPsAAttCDPVVEEHFRRSLGKNYKEP |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14980 | S1862 | Sugiyama | NUMA1 NMP22 NUMA | PAsQAsLRAtsstQsLARLGsPDYGNsALLsLPGyRPttRs |
| Q14980 | T2000 | Sugiyama | NUMA1 NMP22 NUMA | GITTRQQRKRVsLEPHQGPGtPEsKKATSCFPRPMtPRDRH |
| Q15084 | S230 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | QTKGKVKLAAVDAtVNQVLAsRYGIRGFPtIKIFQKGEsPV |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15637 | S89 | Sugiyama | SF1 ZFM1 ZNF162 | DLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTRKKLEEER |
| Q15773 | S240 | Sugiyama | MLF2 | GGRRAEGPPRLAIQGPEDsPsRQsRRYDW____________ |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16543 | T370 | Sugiyama | CDC37 CDC37A | EAKEGEEAGPGDPLLEAVPKtGDEKDVsV____________ |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q5TDH0 | T104 | Sugiyama | DDI2 | PPVQFPNLPRIDFsSIAVPGtssPRQRQPPGtQQsHssPGE |
| Q6GYQ0 | T1002 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | TITGSESASPVHSPLGSRsQtPsPSTLNIDHMEQKDLQLDE |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PKG0 | T769 | Sugiyama | LARP1 KIAA0731 LARP | ALANKLFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtP |
| Q6QNY0 | T16 | Sugiyama | BLOC1S3 BLOS3 | _____MASQGRRRRPLRRPEtVVPGEAtEtDsERsAsssEE |
| Q6XQN6 | S513 | Sugiyama | NAPRT FHIP NAPRT1 | SRALAQLsLSRLSPEHRRLRsPAQYQVVLSERLQALVNSLC |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71RC2 | S597 | Sugiyama | LARP4 PP13296 | QttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEPRKL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86X29 | S365 | Sugiyama | LSR ILDR3 LISCH | MGPAYNGYPGGYPGDVDRsssAGGQGsyVPLLRDTDssVAs |
| Q8IWS0 | S346 | Sugiyama | PHF6 CENP-31 KIAA1823 | CKNHSGNDERDEEDEERESKsRGKVEIDQQQLtQQQLNGN_ |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N1G4 | T27 | Sugiyama | LRRC47 KIAA1185 | SESWPELELAERERRRELLLtGPGLEERVRAAGGQLPPRLF |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBP7 | S488 | Sugiyama | PCSK9 NARC1 PSEC0052 | TRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKLV |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NFI4 | S181 | Sugiyama | ST13P5 FAM10A5 | LQKPNAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEA |
| Q8WZA9 | S44 | Sugiyama | IRGQ IRGQ1 FKSG27 | IAALCDKDVEtLEAPEGRPDsGVPSLRAAGPGLFLGELSCP |
| Q96EP5 | S204 | Sugiyama | DAZAP1 | EVKRAEPRDsKsQAPGQPGAsQWGsRVVPNAANGWAGQPPP |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96QR8 | S23 | Sugiyama | PURB | DGDsGsERGGGGGPCGFQPAsRGGGEQEtQELASKRLDIQN |
| Q9BQ52 | S796 | Sugiyama | ELAC2 HPC2 | EEMEERREKRELRQVRAALLsRELAGGLEDGEPQQKRAHTE |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S983 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sGGsSRtLDAQDRsFGtRPLssGFsPEEAQQQDEEFEKKIP |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H4A3 | S167 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | AVAGPAPSTVPSSTSKDRPVsQPsLVGsKEEPPPARsGsGG |
| Q9H7E2 | S358 | Sugiyama | TDRD3 | RDSQNSKsVLEGSGLPRNRGsERPSTssVsEVWAEDRIKCD |
| Q9H7E2 | S365 | Sugiyama | TDRD3 | sVLEGSGLPRNRGsERPSTssVsEVWAEDRIKCDRPYSRYD |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NTJ3 | S22 | Sugiyama | SMC4 CAPC SMC4L1 | PRKGTQPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsP |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NY61 | S61 | Sugiyama | AATF CHE1 DED HSPC277 | DEGEDGEGDFLVVGsIRKLAsAsLLDtDKRYCGKTTSRKAW |
| Q9NYM9 | S9 | Sugiyama | BET1L GS15 | ____________MADWARAQsPGAVEEILDRENKRMADSLA |
| Q9NZB2 | T991 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | PLQVVSVGGPARGRPRGVIstPVIRTFGRGGRYYGRGYKNQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UQ07 | S315 | Sugiyama | MOK RAGE RAGE1 | ALGSHRKAGFPEHPVAPEPLsNsCQIsKEGRKQKQSLKQEE |
| Q9UQ07 | S317 | Sugiyama | MOK RAGE RAGE1 | GSHRKAGFPEHPVAPEPLsNsCQIsKEGRKQKQSLKQEEDR |
| Q9UQ07 | S321 | Sugiyama | MOK RAGE RAGE1 | KAGFPEHPVAPEPLsNsCQIsKEGRKQKQSLKQEEDRPKRR |
| Q9UQ07 | S364 | Sugiyama | MOK RAGE RAGE1 | AYVMELPKLKLSGVVRLSSYssPTLQSVLGSGTNGRVPVLR |
| Q9UQ07 | S365 | Sugiyama | MOK RAGE RAGE1 | YVMELPKLKLSGVVRLSSYssPTLQSVLGSGTNGRVPVLRP |
| Q9UQ07 | S41 | Sugiyama | MOK RAGE RAGE1 | MQSLRDGNYYACKQMKQRFEsIEQVNNLREIQALRRLNPHP |
| Q9UQ07 | T159 | Sugiyama | MOK RAGE RAGE1 | DVLKLGDFGSCRSVYSKQPYtEyISTRWYRAPECLLTDGFY |
| Q9UQ07 | T220 | Sugiyama | MOK RAGE RAGE1 | PLFPGVNELDQISKIHDVIGtPAQKILTKFKQSRAMNFDFP |
| Q9UQ07 | Y161 | Sugiyama | MOK RAGE RAGE1 | LKLGDFGSCRSVYSKQPYtEyISTRWYRAPECLLTDGFYTY |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9UQ35 | S322 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RRGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDK |
| Q9UQ35 | S323 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RGEGDAPFsEPGttstQRPssPEtAtKQPssPYEDKDKDKK |
| Q9UQ35 | T328 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APFsEPGttstQRPssPEtAtKQPssPYEDKDKDKKEKsAt |
| Q9Y262 | T248 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | LNVLHSLVDKSNINRQLEVytsGGDPEsVAGEyGRHSLYKM |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2V2 | T45 | Sugiyama | CARHSP1 | RsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.102953e-09 | 8.508 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.609431e-06 | 5.793 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.985915e-06 | 5.702 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.659643e-06 | 5.437 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.383087e-05 | 4.859 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.995054e-05 | 4.700 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.396920e-05 | 4.357 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.343676e-05 | 4.272 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.348025e-05 | 4.197 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.527762e-05 | 4.185 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.003297e-05 | 4.097 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.788094e-05 | 4.009 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.176498e-04 | 3.929 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.369369e-04 | 3.863 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.715242e-04 | 3.766 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.752626e-04 | 3.756 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.701455e-04 | 3.769 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.723474e-04 | 3.764 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.044079e-04 | 3.690 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.264778e-04 | 3.645 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.264778e-04 | 3.645 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.446861e-04 | 3.611 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.689401e-04 | 3.570 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.668911e-04 | 3.574 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.894249e-04 | 3.410 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.256641e-04 | 3.371 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.462175e-04 | 3.263 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.462175e-04 | 3.263 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.636909e-04 | 3.178 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.070723e-04 | 3.151 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.310824e-04 | 3.136 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.310824e-04 | 3.136 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.310824e-04 | 3.136 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.065085e-04 | 3.151 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.472214e-04 | 3.072 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.640293e-04 | 3.016 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.712968e-04 | 3.013 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.253832e-03 | 2.902 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.365450e-03 | 2.865 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.492065e-03 | 2.826 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.595628e-03 | 2.797 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.022285e-03 | 2.694 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.984674e-03 | 2.702 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.027262e-03 | 2.693 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.352474e-03 | 2.628 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.352474e-03 | 2.628 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.194558e-03 | 2.659 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.094872e-03 | 2.679 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.266699e-03 | 2.645 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.266699e-03 | 2.645 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.262327e-03 | 2.645 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.119144e-03 | 2.674 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.567281e-03 | 2.591 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.749390e-03 | 2.561 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.929445e-03 | 2.533 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.962305e-03 | 2.528 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.136066e-03 | 2.504 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.261136e-03 | 2.487 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.215727e-03 | 2.493 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.595715e-03 | 2.444 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.841514e-03 | 2.415 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.303689e-03 | 2.366 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.666816e-03 | 2.331 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.753576e-03 | 2.323 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.753576e-03 | 2.323 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.476185e-03 | 2.262 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.284852e-03 | 2.277 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.962328e-03 | 2.225 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.832111e-03 | 2.234 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.083642e-03 | 2.216 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.355697e-03 | 2.197 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.702608e-03 | 2.174 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.939584e-03 | 2.159 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.509063e-03 | 2.124 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.165436e-03 | 2.145 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.509063e-03 | 2.124 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.869382e-03 | 2.104 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.963034e-03 | 2.099 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.064229e-03 | 2.093 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.869382e-03 | 2.104 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.869382e-03 | 2.104 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.579943e-03 | 2.120 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.385066e-03 | 2.076 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.540787e-03 | 2.069 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.540787e-03 | 2.069 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.376717e-03 | 2.028 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.982859e-03 | 2.047 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.333974e-03 | 2.030 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.732448e-03 | 2.012 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.906506e-03 | 2.004 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.041916e-02 | 1.982 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.091805e-02 | 1.962 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.215558e-02 | 1.915 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.131626e-02 | 1.946 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.215558e-02 | 1.915 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.183895e-02 | 1.927 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.335620e-02 | 1.874 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.265131e-02 | 1.898 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.288556e-02 | 1.890 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.294503e-02 | 1.888 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.293640e-02 | 1.888 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.259738e-02 | 1.900 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.335620e-02 | 1.874 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.385247e-02 | 1.858 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.444783e-02 | 1.840 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.451371e-02 | 1.838 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.656543e-02 | 1.781 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.579461e-02 | 1.801 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.622051e-02 | 1.790 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.528743e-02 | 1.816 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.621914e-02 | 1.790 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.528743e-02 | 1.816 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.671770e-02 | 1.777 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.674227e-02 | 1.776 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.700957e-02 | 1.769 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.706248e-02 | 1.768 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.706248e-02 | 1.768 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.883633e-02 | 1.725 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.791019e-02 | 1.747 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.923790e-02 | 1.716 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.883633e-02 | 1.725 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.821126e-02 | 1.740 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.940620e-02 | 1.712 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.940620e-02 | 1.712 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.994042e-02 | 1.700 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.029439e-02 | 1.693 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.075166e-02 | 1.683 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.253020e-02 | 1.647 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.253020e-02 | 1.647 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.253020e-02 | 1.647 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.194854e-02 | 1.659 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.117595e-02 | 1.674 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.029439e-02 | 1.693 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.059625e-02 | 1.686 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.268364e-02 | 1.644 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.456245e-02 | 1.610 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.475177e-02 | 1.606 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.508458e-02 | 1.601 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.510829e-02 | 1.600 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.510829e-02 | 1.600 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.549925e-02 | 1.593 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.965060e-02 | 1.528 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.821194e-02 | 1.550 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.843728e-02 | 1.546 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.848478e-02 | 1.545 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.921984e-02 | 1.534 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.776704e-02 | 1.556 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.073761e-02 | 1.512 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.076285e-02 | 1.512 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.126925e-02 | 1.505 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.428292e-02 | 1.465 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.428292e-02 | 1.465 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 4.687095e-02 | 1.329 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 4.687095e-02 | 1.329 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.687095e-02 | 1.329 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 4.687095e-02 | 1.329 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 4.687095e-02 | 1.329 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 4.687095e-02 | 1.329 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.687095e-02 | 1.329 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 4.687095e-02 | 1.329 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 4.687095e-02 | 1.329 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 4.687095e-02 | 1.329 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 4.687095e-02 | 1.329 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 4.687095e-02 | 1.329 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 4.687095e-02 | 1.329 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 4.687095e-02 | 1.329 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 4.687095e-02 | 1.329 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 4.687095e-02 | 1.329 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 4.687095e-02 | 1.329 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 4.687095e-02 | 1.329 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 4.687095e-02 | 1.329 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.523470e-02 | 1.345 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.523470e-02 | 1.345 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.655125e-02 | 1.437 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.655125e-02 | 1.437 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.285637e-02 | 1.368 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.795954e-02 | 1.421 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.525536e-02 | 1.344 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.285637e-02 | 1.368 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.696108e-02 | 1.432 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.050658e-02 | 1.392 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.696671e-02 | 1.432 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.581332e-02 | 1.446 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.795954e-02 | 1.421 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.795954e-02 | 1.421 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.848267e-02 | 1.415 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.100275e-02 | 1.387 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.285637e-02 | 1.368 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.165013e-02 | 1.380 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.165013e-02 | 1.380 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.152816e-02 | 1.382 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.285637e-02 | 1.368 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.256470e-02 | 1.371 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.006294e-02 | 1.397 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.960876e-02 | 1.402 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.839234e-02 | 1.416 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.433072e-02 | 1.353 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.747069e-02 | 1.324 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.816957e-02 | 1.317 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.816957e-02 | 1.317 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.826262e-02 | 1.316 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.826262e-02 | 1.316 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.826262e-02 | 1.316 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.826262e-02 | 1.316 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.959829e-02 | 1.305 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.966730e-02 | 1.304 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.966730e-02 | 1.304 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.966730e-02 | 1.304 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.966730e-02 | 1.304 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.139405e-02 | 1.289 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.139789e-02 | 1.289 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.267645e-02 | 1.278 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.728133e-02 | 1.242 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.154213e-02 | 1.211 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.397803e-02 | 1.194 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.388403e-02 | 1.269 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.388403e-02 | 1.269 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.817990e-02 | 1.235 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.495676e-02 | 1.260 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.697066e-02 | 1.244 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.465062e-02 | 1.262 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.734957e-02 | 1.241 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.864049e-02 | 1.232 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.837789e-02 | 1.234 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.465062e-02 | 1.262 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.465062e-02 | 1.262 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.397803e-02 | 1.194 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.495676e-02 | 1.260 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.475100e-02 | 1.189 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.475100e-02 | 1.189 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.475100e-02 | 1.189 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.593176e-02 | 1.181 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.670067e-02 | 1.176 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.759876e-02 | 1.170 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.798821e-02 | 1.168 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.894143e-02 | 1.162 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.029640e-02 | 1.153 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.416291e-02 | 1.075 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.416291e-02 | 1.075 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.416291e-02 | 1.075 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.299110e-02 | 1.137 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.299110e-02 | 1.137 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.644184e-02 | 1.117 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.842113e-02 | 1.106 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.700115e-02 | 1.060 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.700115e-02 | 1.060 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.394162e-02 | 1.076 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.897742e-02 | 1.102 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.897742e-02 | 1.102 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.897742e-02 | 1.102 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.308423e-02 | 1.080 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.842113e-02 | 1.106 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.006693e-02 | 1.154 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.842113e-02 | 1.106 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.842113e-02 | 1.106 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.283211e-02 | 1.138 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.006693e-02 | 1.154 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.394162e-02 | 1.076 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.167225e-02 | 1.088 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.006693e-02 | 1.154 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.029640e-02 | 1.153 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.167225e-02 | 1.088 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.421300e-02 | 1.130 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.927350e-02 | 1.101 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 8.416291e-02 | 1.075 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.416291e-02 | 1.075 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.362447e-02 | 1.078 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.362447e-02 | 1.078 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.362447e-02 | 1.078 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.197116e-02 | 1.143 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.723027e-02 | 1.059 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 8.416291e-02 | 1.075 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.394162e-02 | 1.076 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.598247e-02 | 1.066 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.723027e-02 | 1.059 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.812879e-02 | 1.055 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 9.154772e-02 | 1.038 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 9.154772e-02 | 1.038 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 9.154772e-02 | 1.038 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 1.341329e-01 | 0.872 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 1.341329e-01 | 0.872 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.341329e-01 | 0.872 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.341329e-01 | 0.872 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.341329e-01 | 0.872 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.341329e-01 | 0.872 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.341329e-01 | 0.872 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.341329e-01 | 0.872 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.341329e-01 | 0.872 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.341329e-01 | 0.872 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.747243e-01 | 0.758 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.747243e-01 | 0.758 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 1.747243e-01 | 0.758 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 1.747243e-01 | 0.758 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 1.747243e-01 | 0.758 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.134151e-01 | 0.671 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.134151e-01 | 0.671 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 2.134151e-01 | 0.671 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.134151e-01 | 0.671 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 9.877269e-02 | 1.005 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 9.877269e-02 | 1.005 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.877269e-02 | 1.005 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.877269e-02 | 1.005 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.140258e-01 | 0.943 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.502943e-01 | 0.602 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.502943e-01 | 0.602 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.502943e-01 | 0.602 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.502943e-01 | 0.602 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.502943e-01 | 0.602 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.502943e-01 | 0.602 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.502943e-01 | 0.602 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.461004e-01 | 0.835 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.461004e-01 | 0.835 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.461004e-01 | 0.835 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.461004e-01 | 0.835 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.461004e-01 | 0.835 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.461004e-01 | 0.835 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.854465e-01 | 0.544 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.854465e-01 | 0.544 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.854465e-01 | 0.544 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.854465e-01 | 0.544 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.627586e-01 | 0.788 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.797327e-01 | 0.745 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.797327e-01 | 0.745 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.797327e-01 | 0.745 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.797327e-01 | 0.745 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.797327e-01 | 0.745 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.797327e-01 | 0.745 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.797327e-01 | 0.745 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.797327e-01 | 0.745 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.797327e-01 | 0.745 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.189525e-01 | 0.496 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.189525e-01 | 0.496 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.189525e-01 | 0.496 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.189525e-01 | 0.496 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.189525e-01 | 0.496 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.189525e-01 | 0.496 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.189525e-01 | 0.496 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.189525e-01 | 0.496 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.203969e-01 | 0.919 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.203969e-01 | 0.919 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.309692e-01 | 0.883 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.002694e-02 | 1.046 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.002694e-02 | 1.046 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.002694e-02 | 1.046 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.722400e-02 | 1.012 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.418531e-01 | 0.848 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.508893e-01 | 0.455 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.508893e-01 | 0.455 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.508893e-01 | 0.455 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.508893e-01 | 0.455 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.508893e-01 | 0.455 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.530257e-01 | 0.815 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.319165e-01 | 0.635 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.319165e-01 | 0.635 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.319165e-01 | 0.635 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.319165e-01 | 0.635 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.319165e-01 | 0.635 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.319165e-01 | 0.635 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.644645e-01 | 0.784 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.644645e-01 | 0.784 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.644645e-01 | 0.784 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.761468e-01 | 0.754 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.761468e-01 | 0.754 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.495463e-01 | 0.603 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.672129e-01 | 0.573 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.544007e-01 | 0.811 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.124346e-01 | 0.673 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 2.124346e-01 | 0.673 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.124346e-01 | 0.673 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.124346e-01 | 0.673 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.248726e-01 | 0.648 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.248726e-01 | 0.648 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.248726e-01 | 0.648 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.248726e-01 | 0.648 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.248726e-01 | 0.648 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.024915e-01 | 0.519 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.374471e-01 | 0.624 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.374471e-01 | 0.624 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.915831e-01 | 0.718 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.300551e-01 | 0.886 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.300551e-01 | 0.886 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.646890e-01 | 0.783 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.012889e-01 | 0.696 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.200307e-01 | 0.495 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.200307e-01 | 0.495 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.200307e-01 | 0.495 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.724881e-01 | 0.763 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.111374e-01 | 0.675 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.629265e-01 | 0.580 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.374603e-01 | 0.472 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.374603e-01 | 0.472 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.374603e-01 | 0.472 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.374603e-01 | 0.472 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.374603e-01 | 0.472 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.374603e-01 | 0.472 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.884982e-01 | 0.725 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.758424e-01 | 0.755 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.972356e-01 | 0.705 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.621505e-01 | 0.581 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.146903e-01 | 0.502 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.726338e-01 | 0.564 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.120095e-01 | 0.674 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.889387e-01 | 0.724 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.046806e-01 | 0.980 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.407042e-01 | 0.468 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.751451e-01 | 0.560 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.259014e-01 | 0.487 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.259014e-01 | 0.487 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.366585e-01 | 0.473 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.366585e-01 | 0.473 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.214401e-01 | 0.655 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.046810e-01 | 0.980 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.915831e-01 | 0.718 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.887212e-01 | 0.540 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.757935e-01 | 0.559 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.305555e-01 | 0.481 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.305555e-01 | 0.481 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 3.200307e-01 | 0.495 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.374471e-01 | 0.624 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.761468e-01 | 0.754 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.501381e-01 | 0.602 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.020410e-01 | 0.695 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.859352e-02 | 1.006 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.915831e-01 | 0.718 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.240675e-01 | 0.489 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.211407e-01 | 0.917 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.211407e-01 | 0.917 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.211407e-01 | 0.917 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.124346e-01 | 0.673 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.111374e-01 | 0.675 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.536904e-01 | 0.451 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.212216e-01 | 0.493 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.672129e-01 | 0.573 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.102399e-02 | 1.041 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.797327e-01 | 0.745 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.820308e-01 | 0.740 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.887212e-01 | 0.540 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.421860e-01 | 0.847 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.146903e-01 | 0.502 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.016923e-01 | 0.520 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.053531e-01 | 0.687 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.407042e-01 | 0.468 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.189525e-01 | 0.496 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.319165e-01 | 0.635 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.369405e-01 | 0.863 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.915831e-01 | 0.718 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.200307e-01 | 0.495 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.887212e-01 | 0.540 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 1.880505e-01 | 0.726 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.012889e-01 | 0.696 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.797327e-01 | 0.745 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.369405e-01 | 0.863 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.828656e-01 | 0.738 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.828656e-01 | 0.738 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.294328e-01 | 0.888 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.350019e-01 | 0.870 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.969566e-01 | 0.706 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.123898e-01 | 0.949 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.328265e-01 | 0.877 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 1.747243e-01 | 0.758 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.854465e-01 | 0.544 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.722400e-02 | 1.012 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.143697e-01 | 0.669 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.508893e-01 | 0.455 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.211407e-01 | 0.917 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.610722e-02 | 1.017 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.634291e-01 | 0.787 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.887212e-01 | 0.540 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.504862e-01 | 0.601 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.366585e-01 | 0.473 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.366585e-01 | 0.473 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.226700e-02 | 1.035 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.501381e-01 | 0.602 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.221037e-01 | 0.913 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.239104e-01 | 0.907 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.743603e-01 | 0.759 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.461004e-01 | 0.835 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.024915e-01 | 0.519 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.934324e-01 | 0.532 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.306347e-01 | 0.637 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.306347e-01 | 0.637 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.306347e-01 | 0.637 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.306347e-01 | 0.637 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.135205e-01 | 0.945 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.269510e-01 | 0.896 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.018447e-01 | 0.992 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.002773e-01 | 0.999 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.309692e-01 | 0.883 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.143697e-01 | 0.669 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.135205e-01 | 0.945 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.200307e-01 | 0.495 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.536904e-01 | 0.451 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.492931e-01 | 0.457 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.096814e-02 | 1.041 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.575838e-01 | 0.589 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 2.502943e-01 | 0.602 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.797327e-01 | 0.745 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.473216e-01 | 0.832 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.941105e-01 | 0.712 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.192487e-01 | 0.659 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.915831e-01 | 0.718 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.941105e-01 | 0.712 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.110727e-01 | 0.676 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.887212e-01 | 0.540 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.079879e-01 | 0.967 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.079879e-01 | 0.967 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.374471e-01 | 0.624 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.259014e-01 | 0.487 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.110727e-01 | 0.676 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.127097e-01 | 0.948 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.211407e-01 | 0.917 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 2.854465e-01 | 0.544 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.627586e-01 | 0.788 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.627586e-01 | 0.788 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.002773e-01 | 0.999 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.797327e-01 | 0.745 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.189525e-01 | 0.496 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.189525e-01 | 0.496 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.969566e-01 | 0.706 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.880505e-01 | 0.726 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.880505e-01 | 0.726 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.001536e-01 | 0.699 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.848740e-01 | 0.545 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.024915e-01 | 0.519 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.024915e-01 | 0.519 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.495322e-01 | 0.825 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.200307e-01 | 0.495 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.629265e-01 | 0.580 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.374603e-01 | 0.472 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.638420e-01 | 0.786 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.146903e-01 | 0.502 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.095772e-01 | 0.960 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.062272e-01 | 0.514 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.638420e-01 | 0.786 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.124561e-01 | 0.949 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.495463e-01 | 0.603 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.350019e-01 | 0.870 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.130601e-01 | 0.947 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.135872e-01 | 0.504 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.399146e-01 | 0.469 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.203420e-01 | 0.920 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.501381e-01 | 0.602 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.495463e-01 | 0.603 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.495463e-01 | 0.603 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.282420e-01 | 0.892 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.508893e-01 | 0.455 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.504862e-01 | 0.601 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.319165e-01 | 0.635 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.306347e-01 | 0.637 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.724586e-01 | 0.763 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.555421e-01 | 0.593 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.189525e-01 | 0.496 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.143697e-01 | 0.669 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.570351e-01 | 0.804 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.557819e-02 | 1.020 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.106086e-01 | 0.956 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.799683e-01 | 0.745 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.378535e-01 | 0.861 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.140258e-01 | 0.943 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.143697e-01 | 0.669 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.345636e-01 | 0.630 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.887212e-01 | 0.540 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.144777e-01 | 0.669 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.919178e-01 | 0.717 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.328265e-01 | 0.877 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.502943e-01 | 0.602 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.298301e-01 | 0.887 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.854465e-01 | 0.544 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.189525e-01 | 0.496 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.143697e-01 | 0.669 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.203420e-01 | 0.920 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.495463e-01 | 0.603 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.124346e-01 | 0.673 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.211181e-01 | 0.655 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.312203e-01 | 0.636 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.276817e-01 | 0.894 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.169004e-01 | 0.499 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.403860e-01 | 0.853 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.134499e-01 | 0.671 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.806069e-01 | 0.743 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.647392e-01 | 0.783 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.421860e-01 | 0.847 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.421860e-01 | 0.847 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.520014e-01 | 0.818 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.672287e-01 | 0.777 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.848740e-01 | 0.545 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.887212e-01 | 0.540 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 2.393728e-01 | 0.621 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.169004e-01 | 0.499 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.298301e-01 | 0.887 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.002773e-01 | 0.999 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.508893e-01 | 0.455 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.508893e-01 | 0.455 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.634291e-01 | 0.787 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.495322e-01 | 0.825 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.758424e-01 | 0.755 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.276993e-01 | 0.485 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.393728e-01 | 0.621 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.321196e-01 | 0.479 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.920189e-02 | 1.050 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.079879e-01 | 0.967 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.024915e-01 | 0.519 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.714270e-01 | 0.566 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.248141e-01 | 0.648 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.777634e-01 | 0.750 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.696007e-01 | 0.569 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.134151e-01 | 0.671 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.502943e-01 | 0.602 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.854465e-01 | 0.544 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.854465e-01 | 0.544 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.854465e-01 | 0.544 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 1.627586e-01 | 0.788 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 3.189525e-01 | 0.496 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.418531e-01 | 0.848 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.508893e-01 | 0.455 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.508893e-01 | 0.455 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.495463e-01 | 0.603 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.672129e-01 | 0.573 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.887212e-01 | 0.540 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.190115e-01 | 0.924 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.203420e-01 | 0.920 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.770553e-01 | 0.752 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.356807e-01 | 0.628 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.518929e-01 | 0.454 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.386375e-01 | 0.622 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.319165e-01 | 0.635 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.492931e-01 | 0.457 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.194187e-01 | 0.496 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.194187e-01 | 0.496 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.530257e-01 | 0.815 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.374471e-01 | 0.624 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.571080e-01 | 0.590 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.418531e-01 | 0.848 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.848740e-01 | 0.545 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.276993e-01 | 0.485 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.311536e-01 | 0.480 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.248726e-01 | 0.648 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.854465e-01 | 0.544 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.854465e-01 | 0.544 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.189525e-01 | 0.496 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.189525e-01 | 0.496 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.189525e-01 | 0.496 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.189525e-01 | 0.496 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.016923e-01 | 0.520 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.294932e-01 | 0.639 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.907226e-01 | 0.537 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.120334e-01 | 0.951 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.374471e-01 | 0.624 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.848740e-01 | 0.545 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.146903e-01 | 0.502 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.347664e-01 | 0.870 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.189525e-01 | 0.496 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.369405e-01 | 0.863 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.644645e-01 | 0.784 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.848740e-01 | 0.545 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.452853e-01 | 0.462 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.319165e-01 | 0.635 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.146903e-01 | 0.502 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.212216e-01 | 0.493 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.238020e-01 | 0.490 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.854465e-01 | 0.544 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.143697e-01 | 0.669 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.672129e-01 | 0.573 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.348315e-01 | 0.629 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.536904e-01 | 0.451 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.229320e-01 | 0.491 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.407042e-01 | 0.468 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 2.124346e-01 | 0.673 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.820308e-01 | 0.740 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.547520e-01 | 0.450 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.547520e-01 | 0.450 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.547520e-01 | 0.450 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.547520e-01 | 0.450 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.548694e-01 | 0.450 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.582044e-01 | 0.446 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.586852e-01 | 0.445 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.666444e-01 | 0.436 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.666444e-01 | 0.436 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.689763e-01 | 0.433 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.689763e-01 | 0.433 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.705605e-01 | 0.431 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.705605e-01 | 0.431 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.718804e-01 | 0.430 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.718804e-01 | 0.430 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.795531e-01 | 0.421 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.800483e-01 | 0.420 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.813304e-01 | 0.419 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.813304e-01 | 0.419 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.813304e-01 | 0.419 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.813304e-01 | 0.419 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.813304e-01 | 0.419 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.813304e-01 | 0.419 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.813304e-01 | 0.419 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.813304e-01 | 0.419 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.865003e-01 | 0.413 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.868871e-01 | 0.412 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.888230e-01 | 0.410 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.888230e-01 | 0.410 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.888230e-01 | 0.410 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.888230e-01 | 0.410 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.888230e-01 | 0.410 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.911443e-01 | 0.408 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.924042e-01 | 0.406 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.924042e-01 | 0.406 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.967775e-01 | 0.401 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.011922e-01 | 0.397 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 4.011922e-01 | 0.397 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.015068e-01 | 0.396 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.055594e-01 | 0.392 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.055594e-01 | 0.392 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.056557e-01 | 0.392 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.103456e-01 | 0.387 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.103456e-01 | 0.387 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.103456e-01 | 0.387 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.103456e-01 | 0.387 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.103456e-01 | 0.387 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.103456e-01 | 0.387 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.103456e-01 | 0.387 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.103456e-01 | 0.387 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.103456e-01 | 0.387 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.130684e-01 | 0.384 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.150148e-01 | 0.382 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.164633e-01 | 0.380 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.178879e-01 | 0.379 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.178879e-01 | 0.379 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.178879e-01 | 0.379 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.178879e-01 | 0.379 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.220718e-01 | 0.375 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.220718e-01 | 0.375 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.220718e-01 | 0.375 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.220718e-01 | 0.375 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 4.220718e-01 | 0.375 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.222190e-01 | 0.374 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.271240e-01 | 0.369 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.304992e-01 | 0.366 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.304992e-01 | 0.366 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.304992e-01 | 0.366 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.331039e-01 | 0.363 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.331039e-01 | 0.363 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.366978e-01 | 0.360 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.380017e-01 | 0.359 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.380017e-01 | 0.359 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.380017e-01 | 0.359 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.380017e-01 | 0.359 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.380017e-01 | 0.359 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.380017e-01 | 0.359 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.380017e-01 | 0.359 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.380017e-01 | 0.359 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.380017e-01 | 0.359 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.380017e-01 | 0.359 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.380017e-01 | 0.359 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.380017e-01 | 0.359 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 4.383445e-01 | 0.358 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.383445e-01 | 0.358 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.383445e-01 | 0.358 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.383445e-01 | 0.358 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.383445e-01 | 0.358 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.383445e-01 | 0.358 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.430105e-01 | 0.354 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.436419e-01 | 0.353 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.436419e-01 | 0.353 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.521711e-01 | 0.345 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.543635e-01 | 0.343 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.543635e-01 | 0.343 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.543635e-01 | 0.343 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 4.543635e-01 | 0.343 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.543635e-01 | 0.343 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.543635e-01 | 0.343 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.543635e-01 | 0.343 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.543635e-01 | 0.343 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.543635e-01 | 0.343 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.554128e-01 | 0.342 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.554128e-01 | 0.342 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.554128e-01 | 0.342 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.629708e-01 | 0.334 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.643623e-01 | 0.333 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.643623e-01 | 0.333 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.643623e-01 | 0.333 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.643623e-01 | 0.333 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.643623e-01 | 0.333 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.643623e-01 | 0.333 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.643623e-01 | 0.333 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.643623e-01 | 0.333 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.643623e-01 | 0.333 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.643623e-01 | 0.333 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.643623e-01 | 0.333 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.676977e-01 | 0.330 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.676977e-01 | 0.330 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.676977e-01 | 0.330 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.676977e-01 | 0.330 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.676977e-01 | 0.330 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.701170e-01 | 0.328 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.701170e-01 | 0.328 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.701170e-01 | 0.328 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 4.701170e-01 | 0.328 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.701170e-01 | 0.328 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.756445e-01 | 0.323 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.798576e-01 | 0.319 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.798576e-01 | 0.319 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.798576e-01 | 0.319 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.812721e-01 | 0.318 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.855946e-01 | 0.314 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.855946e-01 | 0.314 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.894879e-01 | 0.310 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.894879e-01 | 0.310 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.894879e-01 | 0.310 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.894879e-01 | 0.310 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.913017e-01 | 0.309 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.918851e-01 | 0.308 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.918851e-01 | 0.308 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.918851e-01 | 0.308 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.953196e-01 | 0.305 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.954085e-01 | 0.305 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.007875e-01 | 0.300 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.007875e-01 | 0.300 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.007875e-01 | 0.300 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.134364e-01 | 0.290 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.134364e-01 | 0.290 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.134364e-01 | 0.290 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.134364e-01 | 0.290 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.134364e-01 | 0.290 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.134364e-01 | 0.290 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.134364e-01 | 0.290 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.134364e-01 | 0.290 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.134364e-01 | 0.290 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.134364e-01 | 0.290 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.134364e-01 | 0.290 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.134491e-01 | 0.290 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.156884e-01 | 0.288 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.253326e-01 | 0.280 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.302913e-01 | 0.275 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.362629e-01 | 0.271 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.362629e-01 | 0.271 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.362629e-01 | 0.271 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.362629e-01 | 0.271 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.362629e-01 | 0.271 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.362629e-01 | 0.271 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.362629e-01 | 0.271 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.362629e-01 | 0.271 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.362629e-01 | 0.271 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.445913e-01 | 0.264 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.445913e-01 | 0.264 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.445913e-01 | 0.264 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.580198e-01 | 0.253 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.580198e-01 | 0.253 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.580198e-01 | 0.253 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.580198e-01 | 0.253 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.580198e-01 | 0.253 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.580198e-01 | 0.253 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.580198e-01 | 0.253 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.580198e-01 | 0.253 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.580198e-01 | 0.253 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.580198e-01 | 0.253 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.580198e-01 | 0.253 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.585848e-01 | 0.253 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.585848e-01 | 0.253 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.587306e-01 | 0.253 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.609396e-01 | 0.251 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.639533e-01 | 0.249 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.718854e-01 | 0.243 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.718854e-01 | 0.243 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.722689e-01 | 0.242 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.722689e-01 | 0.242 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.734696e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.779491e-01 | 0.238 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.787572e-01 | 0.238 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.787572e-01 | 0.238 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.787572e-01 | 0.238 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.787572e-01 | 0.238 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.787572e-01 | 0.238 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.787572e-01 | 0.238 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.787572e-01 | 0.238 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.825747e-01 | 0.235 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.837468e-01 | 0.234 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.856420e-01 | 0.232 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.917560e-01 | 0.228 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.919138e-01 | 0.228 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.932613e-01 | 0.227 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.932613e-01 | 0.227 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.985228e-01 | 0.223 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.985228e-01 | 0.223 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.985228e-01 | 0.223 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 5.985228e-01 | 0.223 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.985228e-01 | 0.223 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.985228e-01 | 0.223 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.985228e-01 | 0.223 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.985228e-01 | 0.223 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.985228e-01 | 0.223 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.985228e-01 | 0.223 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.985228e-01 | 0.223 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.987030e-01 | 0.223 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.989160e-01 | 0.223 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.007880e-01 | 0.221 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.114519e-01 | 0.214 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.114519e-01 | 0.214 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.114519e-01 | 0.214 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.114519e-01 | 0.214 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.158729e-01 | 0.211 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.173621e-01 | 0.209 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.173621e-01 | 0.209 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.173621e-01 | 0.209 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.173621e-01 | 0.209 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.173621e-01 | 0.209 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.236731e-01 | 0.205 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.238891e-01 | 0.205 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.238891e-01 | 0.205 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.238891e-01 | 0.205 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.238891e-01 | 0.205 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.239998e-01 | 0.205 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.338854e-01 | 0.198 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.353185e-01 | 0.197 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.353185e-01 | 0.197 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.353185e-01 | 0.197 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.353185e-01 | 0.197 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 6.353185e-01 | 0.197 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.353185e-01 | 0.197 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.353185e-01 | 0.197 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.353185e-01 | 0.197 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.353185e-01 | 0.197 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.356846e-01 | 0.197 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.360159e-01 | 0.197 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 6.360159e-01 | 0.197 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.360159e-01 | 0.197 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.435889e-01 | 0.191 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.440932e-01 | 0.191 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.445543e-01 | 0.191 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.463181e-01 | 0.190 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.524333e-01 | 0.185 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.524333e-01 | 0.185 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.524333e-01 | 0.185 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.524333e-01 | 0.185 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.524333e-01 | 0.185 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.531093e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.531093e-01 | 0.185 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.539077e-01 | 0.184 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.593455e-01 | 0.181 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.593455e-01 | 0.181 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.624464e-01 | 0.179 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.624464e-01 | 0.179 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.644907e-01 | 0.178 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.684304e-01 | 0.175 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.687458e-01 | 0.175 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.687458e-01 | 0.175 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.687458e-01 | 0.175 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.687458e-01 | 0.175 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.687458e-01 | 0.175 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.687458e-01 | 0.175 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.687458e-01 | 0.175 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.687458e-01 | 0.175 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.687458e-01 | 0.175 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.705533e-01 | 0.174 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.705533e-01 | 0.174 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.715998e-01 | 0.173 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.735037e-01 | 0.172 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.755401e-01 | 0.170 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.814606e-01 | 0.167 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 6.814606e-01 | 0.167 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.842937e-01 | 0.165 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.842937e-01 | 0.165 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.842937e-01 | 0.165 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.842937e-01 | 0.165 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.842937e-01 | 0.165 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.842937e-01 | 0.165 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.842937e-01 | 0.165 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.842937e-01 | 0.165 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.842937e-01 | 0.165 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.842937e-01 | 0.165 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.914785e-01 | 0.160 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.920707e-01 | 0.160 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.953645e-01 | 0.158 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.991127e-01 | 0.155 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.991127e-01 | 0.155 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.991127e-01 | 0.155 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.991127e-01 | 0.155 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.991127e-01 | 0.155 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.991127e-01 | 0.155 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.991127e-01 | 0.155 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.991127e-01 | 0.155 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.063827e-01 | 0.151 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.063827e-01 | 0.151 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.095520e-01 | 0.149 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.095520e-01 | 0.149 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.124154e-01 | 0.147 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.124154e-01 | 0.147 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.124154e-01 | 0.147 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.132370e-01 | 0.147 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.132370e-01 | 0.147 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.132370e-01 | 0.147 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.132370e-01 | 0.147 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.136441e-01 | 0.147 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.210033e-01 | 0.142 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.221586e-01 | 0.141 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.221586e-01 | 0.141 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.221586e-01 | 0.141 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.226850e-01 | 0.141 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.227453e-01 | 0.141 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.266990e-01 | 0.139 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.266990e-01 | 0.139 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.266990e-01 | 0.139 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.266990e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.266990e-01 | 0.139 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.266990e-01 | 0.139 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.266990e-01 | 0.139 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.266990e-01 | 0.139 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.266990e-01 | 0.139 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.266990e-01 | 0.139 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.305675e-01 | 0.136 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.316216e-01 | 0.136 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.343746e-01 | 0.134 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.348089e-01 | 0.134 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.374449e-01 | 0.132 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.379009e-01 | 0.132 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.382729e-01 | 0.132 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.395299e-01 | 0.131 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.395299e-01 | 0.131 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.395299e-01 | 0.131 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.395299e-01 | 0.131 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.395299e-01 | 0.131 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.395299e-01 | 0.131 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.395299e-01 | 0.131 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.408094e-01 | 0.130 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.424050e-01 | 0.129 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.517592e-01 | 0.124 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.517592e-01 | 0.124 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.517592e-01 | 0.124 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.531586e-01 | 0.123 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.533117e-01 | 0.123 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.545429e-01 | 0.122 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.583792e-01 | 0.120 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.603424e-01 | 0.119 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.634149e-01 | 0.117 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.634149e-01 | 0.117 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.634149e-01 | 0.117 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.634149e-01 | 0.117 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.667716e-01 | 0.115 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.673560e-01 | 0.115 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.745241e-01 | 0.111 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.745241e-01 | 0.111 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.745241e-01 | 0.111 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.745241e-01 | 0.111 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.745241e-01 | 0.111 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.745241e-01 | 0.111 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.745241e-01 | 0.111 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.755476e-01 | 0.110 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.808813e-01 | 0.107 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.812128e-01 | 0.107 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.827978e-01 | 0.106 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.827978e-01 | 0.106 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.827978e-01 | 0.106 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.827978e-01 | 0.106 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.848884e-01 | 0.105 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.851123e-01 | 0.105 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.851123e-01 | 0.105 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.851123e-01 | 0.105 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.859487e-01 | 0.105 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.905849e-01 | 0.102 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.905849e-01 | 0.102 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.929383e-01 | 0.101 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.952038e-01 | 0.100 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.952038e-01 | 0.100 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.952038e-01 | 0.100 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.952038e-01 | 0.100 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.952038e-01 | 0.100 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.952038e-01 | 0.100 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.952038e-01 | 0.100 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.952038e-01 | 0.100 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.952038e-01 | 0.100 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 7.952038e-01 | 0.100 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.999470e-01 | 0.097 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.027971e-01 | 0.095 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.048221e-01 | 0.094 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.048221e-01 | 0.094 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.048221e-01 | 0.094 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.048221e-01 | 0.094 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.050227e-01 | 0.094 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.118704e-01 | 0.091 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.119691e-01 | 0.090 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.119691e-01 | 0.090 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.119691e-01 | 0.090 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.139891e-01 | 0.089 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.139891e-01 | 0.089 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.139891e-01 | 0.089 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.160437e-01 | 0.088 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.227262e-01 | 0.085 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.227262e-01 | 0.085 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.227262e-01 | 0.085 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.227262e-01 | 0.085 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.227262e-01 | 0.085 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.244791e-01 | 0.084 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.252022e-01 | 0.083 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.271375e-01 | 0.082 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.310534e-01 | 0.080 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.310534e-01 | 0.080 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.310534e-01 | 0.080 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.310534e-01 | 0.080 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.314998e-01 | 0.080 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.314998e-01 | 0.080 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.365526e-01 | 0.078 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.365561e-01 | 0.078 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.375921e-01 | 0.077 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.389898e-01 | 0.076 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.389898e-01 | 0.076 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.404256e-01 | 0.076 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.434843e-01 | 0.074 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.434843e-01 | 0.074 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.440835e-01 | 0.074 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.442241e-01 | 0.074 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.453220e-01 | 0.073 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.455418e-01 | 0.073 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.465540e-01 | 0.072 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.465540e-01 | 0.072 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.465540e-01 | 0.072 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.491820e-01 | 0.071 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.537055e-01 | 0.069 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.537055e-01 | 0.069 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.537055e-01 | 0.069 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.537632e-01 | 0.069 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.537632e-01 | 0.069 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.537632e-01 | 0.069 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.537632e-01 | 0.069 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.537632e-01 | 0.069 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 8.546902e-01 | 0.068 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.600143e-01 | 0.065 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.606341e-01 | 0.065 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.606341e-01 | 0.065 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.606341e-01 | 0.065 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.621283e-01 | 0.064 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.628052e-01 | 0.064 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.651594e-01 | 0.063 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 8.661979e-01 | 0.062 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.671826e-01 | 0.062 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.671826e-01 | 0.062 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.671826e-01 | 0.062 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.701305e-01 | 0.060 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.734238e-01 | 0.059 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.734238e-01 | 0.059 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.734238e-01 | 0.059 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.734238e-01 | 0.059 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.793720e-01 | 0.056 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.793720e-01 | 0.056 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.793720e-01 | 0.056 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.795706e-01 | 0.056 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.840494e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.850411e-01 | 0.053 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.871830e-01 | 0.052 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.883735e-01 | 0.051 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.883735e-01 | 0.051 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.904441e-01 | 0.050 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.925477e-01 | 0.049 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.943119e-01 | 0.049 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.944052e-01 | 0.048 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.955934e-01 | 0.048 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.955934e-01 | 0.048 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.955934e-01 | 0.048 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.955934e-01 | 0.048 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.974346e-01 | 0.047 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.005010e-01 | 0.046 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.005010e-01 | 0.046 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.005010e-01 | 0.046 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.033921e-01 | 0.044 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.042156e-01 | 0.044 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.042156e-01 | 0.044 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.051782e-01 | 0.043 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.051782e-01 | 0.043 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.051782e-01 | 0.043 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.096359e-01 | 0.041 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.096359e-01 | 0.041 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.096359e-01 | 0.041 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.103614e-01 | 0.041 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.113250e-01 | 0.040 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.136440e-01 | 0.039 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.136440e-01 | 0.039 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.138842e-01 | 0.039 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.179330e-01 | 0.037 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.179330e-01 | 0.037 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.179330e-01 | 0.037 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.179376e-01 | 0.037 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.179376e-01 | 0.037 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.217918e-01 | 0.035 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.217918e-01 | 0.035 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.217918e-01 | 0.035 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.217918e-01 | 0.035 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.244495e-01 | 0.034 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.254693e-01 | 0.034 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.254693e-01 | 0.034 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.271797e-01 | 0.033 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.271797e-01 | 0.033 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.323143e-01 | 0.030 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.323143e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.323143e-01 | 0.030 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.354976e-01 | 0.029 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.354976e-01 | 0.029 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.354976e-01 | 0.029 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.354976e-01 | 0.029 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.393457e-01 | 0.027 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.400214e-01 | 0.027 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.414226e-01 | 0.026 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.414226e-01 | 0.026 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.414226e-01 | 0.026 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.423475e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.431016e-01 | 0.025 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.431016e-01 | 0.025 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.431016e-01 | 0.025 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.432465e-01 | 0.025 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.441780e-01 | 0.025 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.445878e-01 | 0.025 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.445878e-01 | 0.025 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.445878e-01 | 0.025 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.448915e-01 | 0.025 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.448915e-01 | 0.025 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.467451e-01 | 0.024 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.468040e-01 | 0.024 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.468040e-01 | 0.024 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.468040e-01 | 0.024 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.485882e-01 | 0.023 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.485882e-01 | 0.023 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.488222e-01 | 0.023 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.493066e-01 | 0.023 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.493066e-01 | 0.023 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.503716e-01 | 0.022 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.508220e-01 | 0.022 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.516916e-01 | 0.022 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.527470e-01 | 0.021 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.537794e-01 | 0.021 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.539646e-01 | 0.020 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.545999e-01 | 0.020 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.550771e-01 | 0.020 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.563832e-01 | 0.019 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.563832e-01 | 0.019 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.580994e-01 | 0.019 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.581950e-01 | 0.019 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.581950e-01 | 0.019 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.597508e-01 | 0.018 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.601623e-01 | 0.018 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.613398e-01 | 0.017 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.620372e-01 | 0.017 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.620372e-01 | 0.017 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.620372e-01 | 0.017 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.620372e-01 | 0.017 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.628684e-01 | 0.016 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.628684e-01 | 0.016 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.628684e-01 | 0.016 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.638239e-01 | 0.016 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.638239e-01 | 0.016 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.639096e-01 | 0.016 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.643389e-01 | 0.016 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.643389e-01 | 0.016 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.655266e-01 | 0.015 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.663520e-01 | 0.015 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.663551e-01 | 0.015 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.665240e-01 | 0.015 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.671493e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.694424e-01 | 0.013 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.694424e-01 | 0.013 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.701694e-01 | 0.013 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.704494e-01 | 0.013 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.708903e-01 | 0.013 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.713544e-01 | 0.013 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.720954e-01 | 0.012 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.729122e-01 | 0.012 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.729122e-01 | 0.012 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.729122e-01 | 0.012 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.731718e-01 | 0.012 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.740680e-01 | 0.011 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.763267e-01 | 0.010 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.763267e-01 | 0.010 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.764339e-01 | 0.010 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.772281e-01 | 0.010 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.776233e-01 | 0.010 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.776652e-01 | 0.010 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.776652e-01 | 0.010 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.781456e-01 | 0.010 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.790271e-01 | 0.009 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.796938e-01 | 0.009 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.797195e-01 | 0.009 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.797195e-01 | 0.009 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.803440e-01 | 0.009 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.810091e-01 | 0.008 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.815850e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.815850e-01 | 0.008 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.815850e-01 | 0.008 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.815850e-01 | 0.008 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.828793e-01 | 0.007 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.829394e-01 | 0.007 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.832792e-01 | 0.007 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.838294e-01 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.839798e-01 | 0.007 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.840670e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.840670e-01 | 0.007 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.840670e-01 | 0.007 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.845415e-01 | 0.007 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.848177e-01 | 0.007 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.855603e-01 | 0.006 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.862646e-01 | 0.006 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.867070e-01 | 0.006 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.867521e-01 | 0.006 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.877198e-01 | 0.005 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.880734e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.891712e-01 | 0.005 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.895246e-01 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.898903e-01 | 0.004 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.906316e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.909409e-01 | 0.004 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.924789e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.926417e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.926417e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.937478e-01 | 0.003 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.938887e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.942791e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.944244e-01 | 0.002 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.947173e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.947534e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.949442e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.949442e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.950009e-01 | 0.002 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.951801e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.952368e-01 | 0.002 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.953818e-01 | 0.002 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.958454e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.969174e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.969722e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.972016e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.972420e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.973338e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.973527e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.974702e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.975256e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.978029e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.978390e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.979888e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.981822e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.984970e-01 | 0.001 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.985082e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.986728e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.991657e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.995117e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.995967e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.997264e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.997419e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998679e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.998769e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999130e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999169e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999343e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999413e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999449e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999644e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999731e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999759e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999804e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999821e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999896e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999964e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999974e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999984e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999999e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.362510e-12 | 11.360 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.625167e-12 | 11.250 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.053766e-09 | 8.296 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.600890e-09 | 8.180 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.899027e-08 | 7.161 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.462534e-07 | 6.835 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.141200e-07 | 6.669 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.027204e-07 | 6.519 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.062620e-06 | 5.974 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110391e-06 | 5.955 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.870403e-06 | 5.728 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.967569e-06 | 5.706 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.974010e-06 | 5.705 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.243578e-06 | 5.649 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.595295e-06 | 5.586 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.595295e-06 | 5.586 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.607697e-06 | 5.584 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.561994e-06 | 5.448 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.085160e-06 | 5.389 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.976093e-06 | 5.401 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.253884e-06 | 5.371 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.838403e-06 | 5.315 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.880098e-06 | 5.312 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.221400e-06 | 5.206 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.507916e-06 | 5.187 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.838592e-06 | 5.165 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.062867e-05 | 4.974 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.145373e-05 | 4.941 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.369327e-05 | 4.863 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.570547e-05 | 4.804 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.684850e-05 | 4.773 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.948620e-05 | 4.710 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.419327e-05 | 4.616 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.511966e-05 | 4.600 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.662706e-05 | 4.575 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.057333e-05 | 4.515 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.126948e-05 | 4.505 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.214396e-05 | 4.493 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.084344e-05 | 4.389 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.154808e-05 | 4.288 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.465969e-05 | 4.262 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.742899e-05 | 4.171 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.781403e-05 | 4.109 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.060538e-05 | 4.043 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.092759e-04 | 3.961 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.096189e-04 | 3.960 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.505534e-04 | 3.822 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.839438e-04 | 3.735 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.027573e-04 | 3.693 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.030588e-04 | 3.692 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.030588e-04 | 3.692 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.200944e-04 | 3.657 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.834537e-04 | 3.548 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.175074e-04 | 3.498 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.331092e-04 | 3.477 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.546891e-04 | 3.450 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.546891e-04 | 3.450 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.931250e-04 | 3.405 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.069881e-04 | 3.390 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.327316e-04 | 3.364 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.003170e-04 | 3.301 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.111686e-04 | 3.214 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.893807e-04 | 3.162 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.619482e-04 | 3.118 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.619482e-04 | 3.118 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.190879e-04 | 3.087 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.088232e-04 | 3.042 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.094789e-03 | 2.961 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.094789e-03 | 2.961 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.070933e-03 | 2.970 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.172037e-03 | 2.931 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.172037e-03 | 2.931 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.284882e-03 | 2.891 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.349398e-03 | 2.870 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.349398e-03 | 2.870 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.407347e-03 | 2.852 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.444429e-03 | 2.840 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.566324e-03 | 2.805 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.570479e-03 | 2.804 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.611083e-03 | 2.793 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.630405e-03 | 2.788 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.795790e-03 | 2.746 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.047593e-03 | 2.689 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.333067e-03 | 2.632 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.504782e-03 | 2.601 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.588482e-03 | 2.587 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.946103e-03 | 2.531 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.598385e-03 | 2.444 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.666032e-03 | 2.436 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.877484e-03 | 2.411 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.138952e-03 | 2.383 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.188108e-03 | 2.378 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.188108e-03 | 2.378 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.589959e-03 | 2.338 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.591505e-03 | 2.338 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.643643e-03 | 2.333 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.894226e-03 | 2.310 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.262291e-03 | 2.279 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.262291e-03 | 2.279 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.379588e-03 | 2.269 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.384684e-03 | 2.269 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.475746e-03 | 2.262 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.978573e-03 | 2.223 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.340627e-03 | 2.198 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.577511e-03 | 2.182 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.800236e-03 | 2.167 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.008630e-03 | 2.154 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.093887e-03 | 2.149 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.751747e-03 | 2.111 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.874723e-03 | 2.104 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.117337e-03 | 2.091 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.430737e-03 | 2.074 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.430737e-03 | 2.074 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.818893e-03 | 2.055 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.818893e-03 | 2.055 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.168925e-03 | 2.038 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.363346e-03 | 2.029 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.802388e-03 | 2.009 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 9.817060e-03 | 2.008 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.031957e-02 | 1.986 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.065692e-02 | 1.972 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.090839e-02 | 1.962 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.102262e-02 | 1.958 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.130508e-02 | 1.947 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.209499e-02 | 1.917 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.209499e-02 | 1.917 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.209499e-02 | 1.917 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.209499e-02 | 1.917 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.214130e-02 | 1.916 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.229545e-02 | 1.910 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.268176e-02 | 1.897 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.289249e-02 | 1.890 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.468732e-02 | 1.833 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.468732e-02 | 1.833 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.468732e-02 | 1.833 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.468732e-02 | 1.833 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.468732e-02 | 1.833 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.394534e-02 | 1.856 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.352409e-02 | 1.869 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.457775e-02 | 1.836 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.406245e-02 | 1.852 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.485614e-02 | 1.828 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.500703e-02 | 1.824 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.553204e-02 | 1.809 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.605108e-02 | 1.794 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.625863e-02 | 1.789 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.625863e-02 | 1.789 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.633627e-02 | 1.787 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.652626e-02 | 1.782 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.655225e-02 | 1.781 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.903388e-02 | 1.720 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.855082e-02 | 1.732 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.875806e-02 | 1.727 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.799709e-02 | 1.745 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.903388e-02 | 1.720 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.710001e-02 | 1.767 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.043176e-02 | 1.690 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.054992e-02 | 1.687 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.137065e-02 | 1.670 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.182847e-02 | 1.661 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.182847e-02 | 1.661 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.185429e-02 | 1.660 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.239350e-02 | 1.650 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.307265e-02 | 1.637 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.447161e-02 | 1.611 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.505378e-02 | 1.601 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.513739e-02 | 1.600 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.513739e-02 | 1.600 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.519827e-02 | 1.599 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.580116e-02 | 1.588 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.625843e-02 | 1.581 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.692545e-02 | 1.570 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.856663e-02 | 1.544 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.918169e-02 | 1.535 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.918169e-02 | 1.535 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.113908e-02 | 1.507 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.113908e-02 | 1.507 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.229386e-02 | 1.491 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.135781e-02 | 1.504 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.447176e-02 | 1.463 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.578204e-02 | 1.446 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.658137e-02 | 1.437 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.763585e-02 | 1.424 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.763585e-02 | 1.424 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.782772e-02 | 1.422 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.784077e-02 | 1.422 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.817755e-02 | 1.418 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.823158e-02 | 1.418 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.823158e-02 | 1.418 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.914095e-02 | 1.407 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.914095e-02 | 1.407 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.044509e-02 | 1.393 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.045111e-02 | 1.393 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.245452e-02 | 1.372 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.188077e-02 | 1.285 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.928662e-02 | 1.307 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.151332e-02 | 1.288 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.758341e-02 | 1.323 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.940161e-02 | 1.306 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.741004e-02 | 1.324 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.983791e-02 | 1.302 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.783999e-02 | 1.320 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.091571e-02 | 1.293 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.510656e-02 | 1.346 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.019630e-02 | 1.299 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.062741e-02 | 1.296 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.983791e-02 | 1.302 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.971427e-02 | 1.304 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.188077e-02 | 1.285 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.218782e-02 | 1.282 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.282425e-02 | 1.277 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.336855e-02 | 1.273 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.544043e-02 | 1.256 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.544043e-02 | 1.256 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.544043e-02 | 1.256 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.614122e-02 | 1.251 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.624238e-02 | 1.250 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.624238e-02 | 1.250 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.624238e-02 | 1.250 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.697044e-02 | 1.244 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.878817e-02 | 1.231 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.957148e-02 | 1.225 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.022471e-02 | 1.220 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.022471e-02 | 1.220 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.138760e-02 | 1.212 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.198456e-02 | 1.208 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.283569e-02 | 1.202 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.452204e-02 | 1.190 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.452204e-02 | 1.190 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.452204e-02 | 1.190 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.452204e-02 | 1.190 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.452204e-02 | 1.190 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.452204e-02 | 1.190 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.166547e-02 | 1.145 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.166547e-02 | 1.145 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.653279e-02 | 1.177 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.210042e-02 | 1.142 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.585917e-02 | 1.181 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.444729e-02 | 1.128 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.522845e-02 | 1.124 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.687776e-02 | 1.175 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.920568e-02 | 1.160 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.001032e-02 | 1.155 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.595690e-02 | 1.119 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.670155e-02 | 1.176 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.901606e-02 | 1.161 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.436415e-02 | 1.129 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.999720e-02 | 1.155 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.690998e-02 | 1.114 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 7.690998e-02 | 1.114 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.690998e-02 | 1.114 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.050144e-02 | 1.094 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.050144e-02 | 1.094 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.059510e-02 | 1.094 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.081314e-02 | 1.093 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.081314e-02 | 1.093 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.344264e-02 | 1.079 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.348926e-02 | 1.078 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.348926e-02 | 1.078 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.412884e-02 | 1.075 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.412884e-02 | 1.075 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.414354e-02 | 1.075 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.414354e-02 | 1.075 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 8.702042e-02 | 1.060 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.161548e-02 | 1.038 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.236889e-02 | 1.034 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.236889e-02 | 1.034 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.361619e-02 | 1.029 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.361619e-02 | 1.029 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.703024e-02 | 1.013 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.747841e-02 | 1.011 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.757368e-02 | 1.011 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.757368e-02 | 1.011 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.800368e-02 | 1.009 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 9.800368e-02 | 1.009 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.810319e-02 | 1.008 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.852931e-02 | 1.006 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.861684e-02 | 1.006 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.045077e-01 | 0.981 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.045077e-01 | 0.981 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.045077e-01 | 0.981 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.168851e-01 | 0.932 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.031200e-01 | 0.987 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.244039e-01 | 0.905 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.244039e-01 | 0.905 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.954082e-02 | 1.002 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.166748e-01 | 0.933 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.168814e-01 | 0.932 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.168851e-01 | 0.932 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.168851e-01 | 0.932 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.116050e-01 | 0.952 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.168851e-01 | 0.932 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.045077e-01 | 0.981 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.119505e-01 | 0.951 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.161433e-01 | 0.935 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.161433e-01 | 0.935 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.054697e-01 | 0.977 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.031200e-01 | 0.987 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.168851e-01 | 0.932 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.053264e-01 | 0.977 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.244039e-01 | 0.905 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.016963e-01 | 0.993 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.168851e-01 | 0.932 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.244904e-01 | 0.905 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.266445e-01 | 0.897 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.268291e-01 | 0.897 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.307883e-01 | 0.883 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.308490e-01 | 0.883 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.312373e-01 | 0.882 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.313829e-01 | 0.881 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.325064e-01 | 0.878 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.342941e-01 | 0.872 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.342941e-01 | 0.872 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.342941e-01 | 0.872 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.403029e-01 | 0.853 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.414013e-01 | 0.850 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.414013e-01 | 0.850 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.414013e-01 | 0.850 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.414013e-01 | 0.850 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.415862e-01 | 0.849 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.415862e-01 | 0.849 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.415862e-01 | 0.849 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.415862e-01 | 0.849 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.420809e-01 | 0.847 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.420809e-01 | 0.847 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.432691e-01 | 0.844 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.439419e-01 | 0.842 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.664730e-01 | 0.779 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 1.664730e-01 | 0.779 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.390155e-01 | 0.622 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.390155e-01 | 0.622 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.390155e-01 | 0.622 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.390155e-01 | 0.622 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.390155e-01 | 0.622 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.390155e-01 | 0.622 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.390155e-01 | 0.622 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.656799e-01 | 0.781 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.052485e-01 | 0.515 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.052485e-01 | 0.515 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.052485e-01 | 0.515 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.052485e-01 | 0.515 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.052485e-01 | 0.515 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.052485e-01 | 0.515 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.052485e-01 | 0.515 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.981616e-01 | 0.703 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.581775e-01 | 0.801 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.581775e-01 | 0.801 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.313111e-01 | 0.636 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.313111e-01 | 0.636 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 2.313111e-01 | 0.636 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.657204e-01 | 0.437 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.657204e-01 | 0.437 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 3.657204e-01 | 0.437 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.657204e-01 | 0.437 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.802792e-01 | 0.744 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.802792e-01 | 0.744 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.802792e-01 | 0.744 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.802792e-01 | 0.744 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.647667e-01 | 0.577 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.647667e-01 | 0.577 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.031480e-01 | 0.692 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.031480e-01 | 0.692 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.600827e-01 | 0.796 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.600827e-01 | 0.796 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.775743e-01 | 0.751 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.266367e-01 | 0.645 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.266367e-01 | 0.645 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.982242e-01 | 0.525 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.982242e-01 | 0.525 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.982242e-01 | 0.525 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 2.982242e-01 | 0.525 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.209320e-01 | 0.376 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.209320e-01 | 0.376 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.209320e-01 | 0.376 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.314302e-01 | 0.480 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.614125e-01 | 0.792 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.749194e-01 | 0.561 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.749194e-01 | 0.561 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.008348e-01 | 0.697 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.008348e-01 | 0.697 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.636770e-01 | 0.786 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.636770e-01 | 0.786 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.636770e-01 | 0.786 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.994554e-01 | 0.524 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.641750e-01 | 0.439 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.713407e-01 | 0.327 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.713407e-01 | 0.327 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.713407e-01 | 0.327 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.713407e-01 | 0.327 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.713407e-01 | 0.327 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.726842e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.726842e-01 | 0.564 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.874048e-01 | 0.727 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.498361e-01 | 0.602 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.962876e-01 | 0.402 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.124374e-01 | 0.673 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.668071e-01 | 0.574 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.129688e-01 | 0.504 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.386125e-01 | 0.622 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.037393e-01 | 0.691 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.037393e-01 | 0.691 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.014402e-01 | 0.521 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.732808e-01 | 0.428 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.276302e-01 | 0.369 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.173640e-01 | 0.286 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.173640e-01 | 0.286 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.173640e-01 | 0.286 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.173640e-01 | 0.286 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.173640e-01 | 0.286 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.173640e-01 | 0.286 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.173640e-01 | 0.286 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.173640e-01 | 0.286 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.679128e-01 | 0.775 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.190158e-01 | 0.496 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.190158e-01 | 0.496 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.369409e-01 | 0.625 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.569198e-01 | 0.590 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.537290e-01 | 0.451 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.537290e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.921441e-01 | 0.716 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.976369e-01 | 0.401 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.580934e-01 | 0.339 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.580934e-01 | 0.339 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.580934e-01 | 0.339 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.078993e-01 | 0.512 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.544760e-01 | 0.450 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.838845e-01 | 0.547 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.217273e-01 | 0.375 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.944883e-01 | 0.404 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.944883e-01 | 0.404 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.450126e-01 | 0.611 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.147332e-01 | 0.382 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.593831e-01 | 0.252 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.593831e-01 | 0.252 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.593831e-01 | 0.252 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.012912e-01 | 0.397 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.688374e-01 | 0.329 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.688374e-01 | 0.329 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.255459e-01 | 0.371 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.160659e-01 | 0.287 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.160659e-01 | 0.287 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.431373e-01 | 0.353 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.937508e-01 | 0.306 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.434673e-01 | 0.265 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.128228e-01 | 0.290 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.559544e-01 | 0.341 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.697681e-01 | 0.244 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.808692e-01 | 0.318 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.232918e-01 | 0.281 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.449385e-01 | 0.264 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.449385e-01 | 0.264 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.779997e-01 | 0.238 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.636770e-01 | 0.786 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.840230e-01 | 0.547 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.281321e-01 | 0.484 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.331542e-01 | 0.632 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.944883e-01 | 0.404 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.988710e-01 | 0.399 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.413863e-01 | 0.355 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.988710e-01 | 0.399 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.988710e-01 | 0.399 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.802792e-01 | 0.744 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.217273e-01 | 0.375 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.610609e-01 | 0.251 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.921441e-01 | 0.716 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.190158e-01 | 0.496 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.598775e-01 | 0.337 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.331542e-01 | 0.632 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.695811e-01 | 0.569 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.779997e-01 | 0.238 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.172609e-01 | 0.380 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.533249e-01 | 0.452 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.695811e-01 | 0.569 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.580934e-01 | 0.339 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.978834e-01 | 0.303 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.718782e-01 | 0.765 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.147332e-01 | 0.382 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.160659e-01 | 0.287 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.994554e-01 | 0.524 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.402699e-01 | 0.619 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.314302e-01 | 0.480 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.749194e-01 | 0.561 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.962876e-01 | 0.402 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.596498e-01 | 0.586 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.950763e-01 | 0.403 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.160659e-01 | 0.287 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.679137e-01 | 0.246 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.487382e-01 | 0.458 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.250232e-01 | 0.648 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.927762e-01 | 0.533 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.802792e-01 | 0.744 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.802792e-01 | 0.744 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.647667e-01 | 0.577 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.014580e-01 | 0.696 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.498361e-01 | 0.602 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.962876e-01 | 0.402 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.732808e-01 | 0.428 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.844572e-01 | 0.546 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.779997e-01 | 0.238 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.701999e-01 | 0.769 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.345177e-01 | 0.362 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.637673e-01 | 0.579 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.637673e-01 | 0.579 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.276302e-01 | 0.369 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.960065e-01 | 0.529 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.882015e-01 | 0.725 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.128228e-01 | 0.290 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.695811e-01 | 0.569 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.901623e-01 | 0.310 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.877191e-01 | 0.726 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.217273e-01 | 0.375 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.454815e-01 | 0.351 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.756040e-01 | 0.425 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.434673e-01 | 0.265 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.656799e-01 | 0.781 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.982242e-01 | 0.525 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.956726e-01 | 0.708 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.743616e-01 | 0.759 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.713407e-01 | 0.327 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.331542e-01 | 0.632 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.240973e-01 | 0.489 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.840230e-01 | 0.547 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.520747e-01 | 0.598 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.215717e-01 | 0.493 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.434673e-01 | 0.265 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.434673e-01 | 0.265 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.705461e-01 | 0.244 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.616690e-01 | 0.251 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.408398e-01 | 0.267 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.790647e-01 | 0.554 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.580934e-01 | 0.339 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.194694e-01 | 0.659 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.424950e-01 | 0.465 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.160659e-01 | 0.287 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.573045e-01 | 0.254 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.209320e-01 | 0.376 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.209320e-01 | 0.376 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.506049e-01 | 0.601 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.713407e-01 | 0.327 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.173640e-01 | 0.286 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.173640e-01 | 0.286 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.758127e-01 | 0.755 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.593831e-01 | 0.252 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.593831e-01 | 0.252 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.688374e-01 | 0.329 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.569947e-01 | 0.340 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.779997e-01 | 0.238 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.111907e-01 | 0.291 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.614125e-01 | 0.792 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.716496e-01 | 0.566 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.321853e-01 | 0.634 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.471247e-01 | 0.350 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.855382e-01 | 0.732 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.523491e-01 | 0.817 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.962876e-01 | 0.402 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.160659e-01 | 0.287 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.160659e-01 | 0.287 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.909970e-01 | 0.408 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.994554e-01 | 0.524 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.874762e-01 | 0.727 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.160659e-01 | 0.287 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.543268e-01 | 0.595 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.315575e-01 | 0.274 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.324761e-01 | 0.634 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.045379e-01 | 0.689 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.276894e-01 | 0.278 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.664730e-01 | 0.779 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.390155e-01 | 0.622 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.390155e-01 | 0.622 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.052485e-01 | 0.515 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.052485e-01 | 0.515 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.052485e-01 | 0.515 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.981616e-01 | 0.703 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.657204e-01 | 0.437 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.802792e-01 | 0.744 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.647667e-01 | 0.577 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.314302e-01 | 0.480 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.168057e-01 | 0.664 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.994554e-01 | 0.524 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.994554e-01 | 0.524 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.713407e-01 | 0.327 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.713407e-01 | 0.327 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.713407e-01 | 0.327 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.726842e-01 | 0.564 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.997679e-01 | 0.699 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.931235e-01 | 0.714 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.988657e-01 | 0.701 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.173640e-01 | 0.286 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.537290e-01 | 0.451 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.580934e-01 | 0.339 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.593831e-01 | 0.252 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.160659e-01 | 0.287 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.490202e-01 | 0.348 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.647632e-01 | 0.333 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.434673e-01 | 0.265 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.573045e-01 | 0.254 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.499288e-01 | 0.260 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.392895e-01 | 0.469 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.902665e-01 | 0.537 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.958824e-01 | 0.708 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.875930e-01 | 0.312 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.986096e-01 | 0.525 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.692967e-01 | 0.433 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.769832e-01 | 0.321 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.722806e-01 | 0.429 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.293603e-01 | 0.276 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.840230e-01 | 0.547 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.732808e-01 | 0.428 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.160659e-01 | 0.287 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.315575e-01 | 0.274 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.967959e-01 | 0.401 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.001030e-01 | 0.699 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 2.982242e-01 | 0.525 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.697681e-01 | 0.244 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.448284e-01 | 0.462 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.389417e-01 | 0.358 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.960065e-01 | 0.529 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.329621e-01 | 0.633 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.713407e-01 | 0.327 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.495140e-01 | 0.825 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.944883e-01 | 0.404 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.593831e-01 | 0.252 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.697681e-01 | 0.244 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.697681e-01 | 0.244 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.328266e-01 | 0.273 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.328266e-01 | 0.273 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.328266e-01 | 0.273 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.756155e-01 | 0.560 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.506049e-01 | 0.601 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.741365e-01 | 0.427 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.520747e-01 | 0.598 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.622030e-01 | 0.441 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.564737e-01 | 0.591 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.656799e-01 | 0.781 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.313111e-01 | 0.636 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.031480e-01 | 0.692 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.276302e-01 | 0.369 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.276302e-01 | 0.369 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.276302e-01 | 0.369 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.085315e-01 | 0.511 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.852944e-01 | 0.414 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.656250e-01 | 0.247 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.657958e-01 | 0.437 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.566238e-01 | 0.805 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.321853e-01 | 0.634 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.844572e-01 | 0.546 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.313111e-01 | 0.636 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.276302e-01 | 0.369 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.222357e-01 | 0.492 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.875930e-01 | 0.312 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.348239e-01 | 0.362 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.360107e-01 | 0.271 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.921441e-01 | 0.716 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.464509e-01 | 0.262 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.348239e-01 | 0.362 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.791881e-01 | 0.421 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.263358e-01 | 0.279 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.499407e-01 | 0.347 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.544760e-01 | 0.450 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.803754e-01 | 0.420 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.390155e-01 | 0.622 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.581775e-01 | 0.801 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.852853e-01 | 0.732 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.994554e-01 | 0.524 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.240973e-01 | 0.489 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.931235e-01 | 0.714 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.173640e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.366787e-01 | 0.473 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.307015e-01 | 0.481 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.547166e-01 | 0.342 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.160659e-01 | 0.287 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.937508e-01 | 0.306 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.944883e-01 | 0.404 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.748569e-01 | 0.561 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.976369e-01 | 0.401 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.610377e-01 | 0.583 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.446760e-01 | 0.611 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.240973e-01 | 0.489 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.976369e-01 | 0.401 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.976369e-01 | 0.401 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.217273e-01 | 0.375 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.659299e-01 | 0.437 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.692056e-01 | 0.245 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.768908e-01 | 0.239 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.740212e-01 | 0.562 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.778890e-01 | 0.321 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.657204e-01 | 0.437 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.982242e-01 | 0.525 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.528825e-01 | 0.597 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.641750e-01 | 0.439 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.608942e-01 | 0.793 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.487382e-01 | 0.458 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.722806e-01 | 0.429 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.743711e-01 | 0.324 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.949941e-01 | 0.305 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.556491e-01 | 0.255 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.732808e-01 | 0.428 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.600827e-01 | 0.796 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.662770e-01 | 0.436 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.499288e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.533249e-01 | 0.452 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.534711e-01 | 0.343 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.052485e-01 | 0.515 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.313111e-01 | 0.636 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.266367e-01 | 0.645 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.982242e-01 | 0.525 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.749194e-01 | 0.561 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.713407e-01 | 0.327 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.840230e-01 | 0.547 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.173640e-01 | 0.286 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.593831e-01 | 0.252 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.078508e-01 | 0.389 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.949941e-01 | 0.305 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.704312e-01 | 0.328 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.686646e-01 | 0.571 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.616690e-01 | 0.251 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.446760e-01 | 0.611 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.749194e-01 | 0.561 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.487382e-01 | 0.458 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.217273e-01 | 0.375 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.835034e-01 | 0.736 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.731883e-01 | 0.564 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.927353e-01 | 0.534 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.927353e-01 | 0.534 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.535215e-01 | 0.596 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.580934e-01 | 0.339 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.160659e-01 | 0.287 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.722806e-01 | 0.429 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.529939e-01 | 0.344 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.732808e-01 | 0.428 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.537290e-01 | 0.451 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.118855e-01 | 0.291 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.949941e-01 | 0.305 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.982242e-01 | 0.525 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.314302e-01 | 0.480 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.487382e-01 | 0.458 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.173640e-01 | 0.286 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.688374e-01 | 0.329 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.160659e-01 | 0.287 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.917408e-01 | 0.308 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.902398e-01 | 0.409 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.829992e-01 | 0.548 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.431373e-01 | 0.353 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.600827e-01 | 0.796 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.543843e-01 | 0.811 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.890279e-01 | 0.723 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.168057e-01 | 0.664 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.173640e-01 | 0.286 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 2.078627e-01 | 0.682 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.556203e-01 | 0.808 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.919933e-01 | 0.535 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.173640e-01 | 0.286 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.593831e-01 | 0.252 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.160659e-01 | 0.287 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.573045e-01 | 0.254 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.864976e-01 | 0.729 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.321853e-01 | 0.634 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.732808e-01 | 0.428 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.936853e-01 | 0.713 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.695811e-01 | 0.569 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.789968e-01 | 0.554 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.997886e-01 | 0.301 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 3.301575e-01 | 0.481 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.917408e-01 | 0.308 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.688374e-01 | 0.329 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.848278e-01 | 0.233 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.854923e-01 | 0.232 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.894028e-01 | 0.230 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.924132e-01 | 0.227 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.949521e-01 | 0.226 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.949521e-01 | 0.226 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.949521e-01 | 0.226 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.949521e-01 | 0.226 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.949521e-01 | 0.226 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.949521e-01 | 0.226 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.949521e-01 | 0.226 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.977462e-01 | 0.223 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.977462e-01 | 0.223 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.977462e-01 | 0.223 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.977462e-01 | 0.223 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.977462e-01 | 0.223 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.977462e-01 | 0.223 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.977462e-01 | 0.223 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.977462e-01 | 0.223 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.977462e-01 | 0.223 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.977462e-01 | 0.223 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.977462e-01 | 0.223 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.977462e-01 | 0.223 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.977462e-01 | 0.223 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 5.977462e-01 | 0.223 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.980748e-01 | 0.223 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.980748e-01 | 0.223 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.980748e-01 | 0.223 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.988614e-01 | 0.223 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.998895e-01 | 0.222 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.026477e-01 | 0.220 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.092045e-01 | 0.215 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.136979e-01 | 0.212 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.144177e-01 | 0.212 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.160421e-01 | 0.210 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.161015e-01 | 0.210 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.175136e-01 | 0.209 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.175136e-01 | 0.209 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.175136e-01 | 0.209 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.190144e-01 | 0.208 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.190144e-01 | 0.208 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.190144e-01 | 0.208 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.190144e-01 | 0.208 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.190144e-01 | 0.208 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.190144e-01 | 0.208 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.193658e-01 | 0.208 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.193658e-01 | 0.208 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.193658e-01 | 0.208 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.193658e-01 | 0.208 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.193658e-01 | 0.208 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.261440e-01 | 0.203 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.300334e-01 | 0.201 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.327713e-01 | 0.199 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.327713e-01 | 0.199 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.327713e-01 | 0.199 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.327713e-01 | 0.199 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.327713e-01 | 0.199 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.327713e-01 | 0.199 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.327713e-01 | 0.199 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.327713e-01 | 0.199 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.327713e-01 | 0.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.327713e-01 | 0.199 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.327713e-01 | 0.199 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 6.327713e-01 | 0.199 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.327713e-01 | 0.199 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.327713e-01 | 0.199 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.356349e-01 | 0.197 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.356349e-01 | 0.197 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.356349e-01 | 0.197 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.363046e-01 | 0.196 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.370129e-01 | 0.196 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.393755e-01 | 0.194 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.403163e-01 | 0.194 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.419595e-01 | 0.192 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.419595e-01 | 0.192 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.419595e-01 | 0.192 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.419595e-01 | 0.192 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.458111e-01 | 0.190 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.458111e-01 | 0.190 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.499260e-01 | 0.187 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.511908e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.514461e-01 | 0.186 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.520510e-01 | 0.186 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.520510e-01 | 0.186 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.523239e-01 | 0.186 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.542292e-01 | 0.184 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.544404e-01 | 0.184 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.570377e-01 | 0.182 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.589561e-01 | 0.181 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.620151e-01 | 0.179 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.637994e-01 | 0.178 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.637994e-01 | 0.178 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.647486e-01 | 0.177 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.647486e-01 | 0.177 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.647486e-01 | 0.177 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.647486e-01 | 0.177 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.647486e-01 | 0.177 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.647486e-01 | 0.177 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.647486e-01 | 0.177 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.647486e-01 | 0.177 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.647486e-01 | 0.177 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.647486e-01 | 0.177 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.647486e-01 | 0.177 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.647486e-01 | 0.177 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.647486e-01 | 0.177 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.647486e-01 | 0.177 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.647486e-01 | 0.177 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.649090e-01 | 0.177 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.649090e-01 | 0.177 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.667925e-01 | 0.176 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.719175e-01 | 0.173 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.719175e-01 | 0.173 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.816694e-01 | 0.166 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.845526e-01 | 0.165 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.845526e-01 | 0.165 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.845526e-01 | 0.165 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.845526e-01 | 0.165 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.845526e-01 | 0.165 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.845526e-01 | 0.165 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.886907e-01 | 0.162 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.887358e-01 | 0.162 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.887358e-01 | 0.162 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.887358e-01 | 0.162 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.887358e-01 | 0.162 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.887358e-01 | 0.162 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.915629e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.924270e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.924270e-01 | 0.160 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.939431e-01 | 0.159 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.939431e-01 | 0.159 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.939431e-01 | 0.159 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.939431e-01 | 0.159 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.939431e-01 | 0.159 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.939431e-01 | 0.159 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.939431e-01 | 0.159 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.939431e-01 | 0.159 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.939431e-01 | 0.159 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.939431e-01 | 0.159 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.939431e-01 | 0.159 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 6.939431e-01 | 0.159 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.939431e-01 | 0.159 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.939431e-01 | 0.159 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.939431e-01 | 0.159 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.959084e-01 | 0.157 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.960743e-01 | 0.157 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.960743e-01 | 0.157 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.960743e-01 | 0.157 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.001891e-01 | 0.155 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.001891e-01 | 0.155 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.026503e-01 | 0.153 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.042427e-01 | 0.152 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.042427e-01 | 0.152 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.042427e-01 | 0.152 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.042427e-01 | 0.152 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.042427e-01 | 0.152 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.042427e-01 | 0.152 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.042427e-01 | 0.152 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.042864e-01 | 0.152 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.042864e-01 | 0.152 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.048981e-01 | 0.152 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.048981e-01 | 0.152 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.092987e-01 | 0.149 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.100062e-01 | 0.149 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.100062e-01 | 0.149 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.100062e-01 | 0.149 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.100062e-01 | 0.149 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.100062e-01 | 0.149 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.126418e-01 | 0.147 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.204101e-01 | 0.142 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.204101e-01 | 0.142 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.204101e-01 | 0.142 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.204101e-01 | 0.142 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.204101e-01 | 0.142 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.205968e-01 | 0.142 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.205968e-01 | 0.142 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.205968e-01 | 0.142 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.205968e-01 | 0.142 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.205968e-01 | 0.142 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.205968e-01 | 0.142 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.205968e-01 | 0.142 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.205968e-01 | 0.142 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.205968e-01 | 0.142 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.205968e-01 | 0.142 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.205968e-01 | 0.142 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.205968e-01 | 0.142 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.205968e-01 | 0.142 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.205968e-01 | 0.142 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.228974e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.228974e-01 | 0.141 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.228974e-01 | 0.141 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.228974e-01 | 0.141 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.228974e-01 | 0.141 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.228974e-01 | 0.141 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.228974e-01 | 0.141 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.234659e-01 | 0.141 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.269096e-01 | 0.139 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.346480e-01 | 0.134 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.352798e-01 | 0.134 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.352798e-01 | 0.134 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.356915e-01 | 0.133 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.364557e-01 | 0.133 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.364557e-01 | 0.133 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.365428e-01 | 0.133 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.405477e-01 | 0.130 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.405477e-01 | 0.130 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.410160e-01 | 0.130 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.429090e-01 | 0.129 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.449308e-01 | 0.128 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.449308e-01 | 0.128 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.449308e-01 | 0.128 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.449308e-01 | 0.128 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.449308e-01 | 0.128 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.449308e-01 | 0.128 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.449308e-01 | 0.128 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.449308e-01 | 0.128 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.449308e-01 | 0.128 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.449308e-01 | 0.128 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.449308e-01 | 0.128 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.449308e-01 | 0.128 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.484697e-01 | 0.126 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.495170e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.495170e-01 | 0.125 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.495170e-01 | 0.125 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.495170e-01 | 0.125 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.495170e-01 | 0.125 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.506999e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.554306e-01 | 0.122 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.572271e-01 | 0.121 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.572271e-01 | 0.121 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.572271e-01 | 0.121 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.574184e-01 | 0.121 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.601822e-01 | 0.119 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.610416e-01 | 0.119 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.622486e-01 | 0.118 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.623521e-01 | 0.118 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.626165e-01 | 0.118 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.631334e-01 | 0.117 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.631334e-01 | 0.117 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.653651e-01 | 0.116 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.671468e-01 | 0.115 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.671468e-01 | 0.115 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.671468e-01 | 0.115 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.671468e-01 | 0.115 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.671468e-01 | 0.115 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.671468e-01 | 0.115 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.671468e-01 | 0.115 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.671468e-01 | 0.115 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.671468e-01 | 0.115 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.671468e-01 | 0.115 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.671468e-01 | 0.115 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.671468e-01 | 0.115 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.671468e-01 | 0.115 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.671468e-01 | 0.115 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.671468e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.726486e-01 | 0.112 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.726486e-01 | 0.112 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.728650e-01 | 0.112 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.728650e-01 | 0.112 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.728650e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.729706e-01 | 0.112 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.729706e-01 | 0.112 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.729706e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.737002e-01 | 0.111 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.749973e-01 | 0.111 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.761425e-01 | 0.110 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.770939e-01 | 0.110 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.781742e-01 | 0.109 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.783741e-01 | 0.109 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.783741e-01 | 0.109 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.825701e-01 | 0.106 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.830185e-01 | 0.106 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.830185e-01 | 0.106 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.831690e-01 | 0.106 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.874290e-01 | 0.104 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.874290e-01 | 0.104 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.874290e-01 | 0.104 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.874290e-01 | 0.104 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.874290e-01 | 0.104 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.874290e-01 | 0.104 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.874290e-01 | 0.104 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.874290e-01 | 0.104 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.874290e-01 | 0.104 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.874290e-01 | 0.104 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.878148e-01 | 0.104 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.878148e-01 | 0.104 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.878148e-01 | 0.104 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.878148e-01 | 0.104 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.885585e-01 | 0.103 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.928171e-01 | 0.101 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.933656e-01 | 0.101 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.945256e-01 | 0.100 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.945256e-01 | 0.100 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.945256e-01 | 0.100 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.978946e-01 | 0.098 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.002407e-01 | 0.097 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.003970e-01 | 0.097 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.017969e-01 | 0.096 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.017969e-01 | 0.096 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.017969e-01 | 0.096 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.017969e-01 | 0.096 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.017969e-01 | 0.096 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.021079e-01 | 0.096 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.033696e-01 | 0.095 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.048120e-01 | 0.094 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.048120e-01 | 0.094 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.059457e-01 | 0.094 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.059457e-01 | 0.094 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.059457e-01 | 0.094 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.059457e-01 | 0.094 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.059457e-01 | 0.094 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.059457e-01 | 0.094 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.059457e-01 | 0.094 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.059457e-01 | 0.094 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.059457e-01 | 0.094 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.093612e-01 | 0.092 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.113708e-01 | 0.091 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.116744e-01 | 0.091 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.146758e-01 | 0.089 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.149543e-01 | 0.089 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.149543e-01 | 0.089 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.201377e-01 | 0.086 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.203277e-01 | 0.086 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.224077e-01 | 0.085 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.228505e-01 | 0.085 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.228505e-01 | 0.085 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.228505e-01 | 0.085 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.228505e-01 | 0.085 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.228505e-01 | 0.085 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.228505e-01 | 0.085 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.228505e-01 | 0.085 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.228505e-01 | 0.085 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.228505e-01 | 0.085 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.228505e-01 | 0.085 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.228505e-01 | 0.085 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.241268e-01 | 0.084 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.242367e-01 | 0.084 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.273246e-01 | 0.082 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.273246e-01 | 0.082 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.273246e-01 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.273246e-01 | 0.082 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.326144e-01 | 0.080 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.326144e-01 | 0.080 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.326144e-01 | 0.080 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.328371e-01 | 0.079 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.331753e-01 | 0.079 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.334627e-01 | 0.079 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.366846e-01 | 0.077 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.376016e-01 | 0.077 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.382835e-01 | 0.077 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.382835e-01 | 0.077 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.382835e-01 | 0.077 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.382835e-01 | 0.077 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.382835e-01 | 0.077 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.382835e-01 | 0.077 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.382835e-01 | 0.077 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.382835e-01 | 0.077 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.382835e-01 | 0.077 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.382835e-01 | 0.077 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.389450e-01 | 0.076 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.389450e-01 | 0.076 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.389450e-01 | 0.076 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.389450e-01 | 0.076 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.389450e-01 | 0.076 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.396117e-01 | 0.076 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.408860e-01 | 0.075 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.423123e-01 | 0.075 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.486402e-01 | 0.071 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.498523e-01 | 0.071 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.501077e-01 | 0.071 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.515196e-01 | 0.070 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.515196e-01 | 0.070 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.523728e-01 | 0.069 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.523728e-01 | 0.069 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.523728e-01 | 0.069 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.523728e-01 | 0.069 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.523728e-01 | 0.069 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.523728e-01 | 0.069 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.523728e-01 | 0.069 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.523728e-01 | 0.069 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.523728e-01 | 0.069 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.602544e-01 | 0.065 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.614743e-01 | 0.065 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.652354e-01 | 0.063 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.652354e-01 | 0.063 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.652354e-01 | 0.063 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.652354e-01 | 0.063 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.652354e-01 | 0.063 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.652354e-01 | 0.063 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.655613e-01 | 0.063 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.655613e-01 | 0.063 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.655613e-01 | 0.063 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.655613e-01 | 0.063 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.655613e-01 | 0.063 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.685349e-01 | 0.061 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.685349e-01 | 0.061 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.685349e-01 | 0.061 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.696708e-01 | 0.061 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.696708e-01 | 0.061 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.696708e-01 | 0.061 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.696708e-01 | 0.061 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.709517e-01 | 0.060 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.727620e-01 | 0.059 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.727620e-01 | 0.059 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.727620e-01 | 0.059 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.769780e-01 | 0.057 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.769780e-01 | 0.057 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.769780e-01 | 0.057 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.769780e-01 | 0.057 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.769780e-01 | 0.057 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.769780e-01 | 0.057 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.769780e-01 | 0.057 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.769780e-01 | 0.057 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.769780e-01 | 0.057 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.769780e-01 | 0.057 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.769780e-01 | 0.057 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.769780e-01 | 0.057 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.786512e-01 | 0.056 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.786512e-01 | 0.056 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.786512e-01 | 0.056 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.796273e-01 | 0.056 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.796273e-01 | 0.056 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.838052e-01 | 0.054 | 0 | 0 |
| Translation | R-HSA-72766 | 8.840215e-01 | 0.054 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.861688e-01 | 0.052 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.870569e-01 | 0.052 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.870569e-01 | 0.052 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.870569e-01 | 0.052 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.876981e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.876981e-01 | 0.052 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.876981e-01 | 0.052 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.876981e-01 | 0.052 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.876981e-01 | 0.052 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.876981e-01 | 0.052 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.876981e-01 | 0.052 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.876981e-01 | 0.052 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.876981e-01 | 0.052 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.908094e-01 | 0.050 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.908307e-01 | 0.050 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.923978e-01 | 0.049 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.926750e-01 | 0.049 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.949198e-01 | 0.048 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.949198e-01 | 0.048 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.949198e-01 | 0.048 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.953128e-01 | 0.048 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.974730e-01 | 0.047 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.974846e-01 | 0.047 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.974846e-01 | 0.047 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.974846e-01 | 0.047 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.974846e-01 | 0.047 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.974846e-01 | 0.047 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.974846e-01 | 0.047 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.974846e-01 | 0.047 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.974846e-01 | 0.047 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.974846e-01 | 0.047 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.974846e-01 | 0.047 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.974846e-01 | 0.047 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.016445e-01 | 0.045 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.022505e-01 | 0.045 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.022708e-01 | 0.045 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.022708e-01 | 0.045 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.022708e-01 | 0.045 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.022708e-01 | 0.045 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.037492e-01 | 0.044 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.037492e-01 | 0.044 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.064188e-01 | 0.043 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.064188e-01 | 0.043 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.064188e-01 | 0.043 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.064188e-01 | 0.043 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.064188e-01 | 0.043 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.064188e-01 | 0.043 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.067026e-01 | 0.043 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.074478e-01 | 0.042 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.091391e-01 | 0.041 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.093239e-01 | 0.041 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.093239e-01 | 0.041 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.096760e-01 | 0.041 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.096760e-01 | 0.041 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.145748e-01 | 0.039 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.145748e-01 | 0.039 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.145748e-01 | 0.039 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.145748e-01 | 0.039 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.145748e-01 | 0.039 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.145748e-01 | 0.039 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.145748e-01 | 0.039 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.152696e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.155532e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.155532e-01 | 0.038 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.205458e-01 | 0.036 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.215400e-01 | 0.035 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.215400e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.220205e-01 | 0.035 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.220205e-01 | 0.035 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.220205e-01 | 0.035 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.220205e-01 | 0.035 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.220205e-01 | 0.035 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.220205e-01 | 0.035 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.231433e-01 | 0.035 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.264251e-01 | 0.033 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.271252e-01 | 0.033 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.271252e-01 | 0.033 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.275044e-01 | 0.033 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.281940e-01 | 0.032 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.281940e-01 | 0.032 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.288176e-01 | 0.032 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.288176e-01 | 0.032 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.288176e-01 | 0.032 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.288176e-01 | 0.032 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.288176e-01 | 0.032 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.306091e-01 | 0.031 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.323215e-01 | 0.030 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.323333e-01 | 0.030 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.323333e-01 | 0.030 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.325238e-01 | 0.030 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.340961e-01 | 0.030 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.348017e-01 | 0.029 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.350226e-01 | 0.029 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.350226e-01 | 0.029 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.350226e-01 | 0.029 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.350226e-01 | 0.029 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.350226e-01 | 0.029 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.350226e-01 | 0.029 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.366336e-01 | 0.028 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.371876e-01 | 0.028 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.371876e-01 | 0.028 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.371876e-01 | 0.028 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.371876e-01 | 0.028 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.376293e-01 | 0.028 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.389530e-01 | 0.027 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.399382e-01 | 0.027 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.406870e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.406870e-01 | 0.027 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.406870e-01 | 0.027 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.406870e-01 | 0.027 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.406870e-01 | 0.027 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.406870e-01 | 0.027 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.406870e-01 | 0.027 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.406870e-01 | 0.027 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.406870e-01 | 0.027 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.406870e-01 | 0.027 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.417103e-01 | 0.026 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.417103e-01 | 0.026 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.426867e-01 | 0.026 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.426867e-01 | 0.026 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.443200e-01 | 0.025 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.451009e-01 | 0.025 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.458580e-01 | 0.024 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.458580e-01 | 0.024 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.458580e-01 | 0.024 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.458580e-01 | 0.024 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.458580e-01 | 0.024 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.459221e-01 | 0.024 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.459846e-01 | 0.024 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.463638e-01 | 0.024 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.474657e-01 | 0.023 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.489464e-01 | 0.023 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.495208e-01 | 0.022 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.498429e-01 | 0.022 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.499067e-01 | 0.022 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.505784e-01 | 0.022 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.505784e-01 | 0.022 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.505784e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.505784e-01 | 0.022 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.505784e-01 | 0.022 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.522606e-01 | 0.021 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.534915e-01 | 0.021 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.534915e-01 | 0.021 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.534915e-01 | 0.021 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.534915e-01 | 0.021 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.544319e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.544319e-01 | 0.020 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.548875e-01 | 0.020 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.548875e-01 | 0.020 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.548875e-01 | 0.020 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.561190e-01 | 0.019 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.574692e-01 | 0.019 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.588212e-01 | 0.018 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.588212e-01 | 0.018 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.600414e-01 | 0.018 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.624120e-01 | 0.017 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.624120e-01 | 0.017 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.624120e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.641928e-01 | 0.016 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.652547e-01 | 0.015 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.654345e-01 | 0.015 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.656899e-01 | 0.015 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.656899e-01 | 0.015 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.656899e-01 | 0.015 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.656899e-01 | 0.015 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.657011e-01 | 0.015 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.657011e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.665576e-01 | 0.015 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.671999e-01 | 0.014 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.686822e-01 | 0.014 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.686822e-01 | 0.014 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.705854e-01 | 0.013 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.714136e-01 | 0.013 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.714136e-01 | 0.013 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.714136e-01 | 0.013 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.727979e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.737310e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.739070e-01 | 0.011 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.739070e-01 | 0.011 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.739070e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.746203e-01 | 0.011 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.746203e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.747953e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.751729e-01 | 0.011 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.761830e-01 | 0.010 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.761830e-01 | 0.010 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.761830e-01 | 0.010 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.761830e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.761830e-01 | 0.010 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.761830e-01 | 0.010 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.761830e-01 | 0.010 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.778543e-01 | 0.010 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.779229e-01 | 0.010 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.782013e-01 | 0.010 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.782606e-01 | 0.010 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.782606e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.782606e-01 | 0.010 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.782606e-01 | 0.010 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.784198e-01 | 0.009 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.786659e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.792397e-01 | 0.009 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.794166e-01 | 0.009 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.797629e-01 | 0.009 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.800373e-01 | 0.009 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.801571e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.801571e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.808135e-01 | 0.008 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.808422e-01 | 0.008 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.818883e-01 | 0.008 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.818883e-01 | 0.008 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.818883e-01 | 0.008 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.818883e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.818883e-01 | 0.008 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.818883e-01 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.823422e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.829214e-01 | 0.007 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.834685e-01 | 0.007 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.834685e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.834685e-01 | 0.007 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.834685e-01 | 0.007 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.834685e-01 | 0.007 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.834685e-01 | 0.007 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.843842e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.844815e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.844815e-01 | 0.007 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.849109e-01 | 0.007 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.849109e-01 | 0.007 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.849109e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.849109e-01 | 0.007 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.850226e-01 | 0.007 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.854087e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.855472e-01 | 0.006 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.862276e-01 | 0.006 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.862276e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.862276e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.862276e-01 | 0.006 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.862276e-01 | 0.006 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.862276e-01 | 0.006 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.865142e-01 | 0.006 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.874294e-01 | 0.005 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.874294e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.875379e-01 | 0.005 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.877956e-01 | 0.005 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.884134e-01 | 0.005 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.884134e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.884134e-01 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.884857e-01 | 0.005 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.885264e-01 | 0.005 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.885264e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.885264e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.891489e-01 | 0.005 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.895278e-01 | 0.005 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.904262e-01 | 0.004 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.904350e-01 | 0.004 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.912162e-01 | 0.004 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.912655e-01 | 0.004 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.912761e-01 | 0.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.912761e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.912761e-01 | 0.004 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.916216e-01 | 0.004 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.920376e-01 | 0.003 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.920376e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.920376e-01 | 0.003 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.922646e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.924488e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.927327e-01 | 0.003 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.927327e-01 | 0.003 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.928328e-01 | 0.003 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.930062e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.930746e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.934089e-01 | 0.003 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.939462e-01 | 0.003 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.939462e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.943870e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.944747e-01 | 0.002 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.946870e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.949572e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.950722e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.952223e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.953975e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.953975e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.954875e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.957806e-01 | 0.002 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.961307e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.961441e-01 | 0.002 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.961663e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.964826e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.965155e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.965435e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.965435e-01 | 0.002 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.968598e-01 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.968743e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.970856e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.971152e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.973402e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.973919e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.975178e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.976411e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.977846e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.979782e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.979782e-01 | 0.001 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.981548e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.981548e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.982672e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.983645e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.983991e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.984010e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.985369e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.992118e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.992631e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.992631e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.993727e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.993843e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.993848e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.994873e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994873e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.995186e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996066e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997529e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998437e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999028e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999172e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999251e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999431e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999568e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999696e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999856e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999858e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999869e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999924e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999952e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999952e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999956e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999958e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999965e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999972e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999975e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999981e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999996e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999996e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |